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Abstract
The overarching theme of this thesis is to develop and apply multi-scale computational
techniques adopted from physical sciences to study a key phenomenon underlying the
adaptive immune response: the activation of T cells. The specific objectives are: 1)
develop efficient and versatile computational frameworks to study multi-scale biological
systems in silico; 2) obtain mechanistic insights into how T cells are triggered in vivo.
The first problem investigated in this thesis addressed a controversy regarding when
and how T cells alter migratory patterns in lymphoid tissues, as observed in intravital
microscopy experiments. By developing a lattice-based model for T cell migration
coupled with a mechanistically motivated simple scheme for T cell activation, I showed
that the quantity and quality of cognate antigen (Ag) presented by dendritic cells (DC)
dictate such changes. The results from theoretical and computational analyses were not
only in agreement with synergistic experiments, but also made predictions that have been
tested positively. Furthermore, I identified a consolidated measure of Ag quantity and
quality, which provides a unifying conceptual framework for considering diverse future
experimental results.
The results from this study also suggested that T cells may integrate sub-optimal
signals derived from successive encounters with DCs to achieve full activation. However,
an underlying molecular mechanism that may confer such "short term memory" of
exposure to Ag is not known. I explored the possibility that the hysteresis resulting from
positive feedback regulation of the catalytic conversion of a G-protein RasGDP to RasGTP
in the T cell receptor (TCR) membrane-proximal signaling network may enable such
"short term memory". I developed a multiscale computational model that combines
stochastic simulations of the TCR membrane-proximal signaling network with T cell
migration. The results showed that this hysteresis can enable T cells to integrate signals
derived from weakly stimulatory DCs and may greatly enhance the detection sensitivity
during disease onset when Ag presentation is low. The computational framework
developed in this study can be readily adapted to examine diverse biological systems
where signaling and cell motion need to be studied simultaneously. For example, the
model was modified to investigate a DC-mediated mechanism for signal integration, and
our results suggest that this mechanism is less likely.
Initial steps were also taken to construct a macroscopic model that aims to study how
T cell activation impacts observations at the organismic level. Preliminary results for how
microscopic receptor-ligand interactions affect the proliferation of different T cell types
are presented. Directions for future research are suggested based on these findings.
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Chapter 1 Introduction
1.1 Background and scope
As experimental tools and techniques become increasingly more sophisticated, biology
has transformed from a descriptive, phenomena-centric field into one that is extremely
data-rich. Not only does this change greatly improve our ability to build and test
mechanistic hypotheses, it also simultaneously calls for investigations in which theory
and experiments are brought together in a complementary fashion.
Physics, mathematics and engineering are beginning to provide powerful tools for the
studying of biological systems. Not only can we borrow established methods from the
physical sciences to process the rich data made available by new experimental
techniques, we also can apply the "reductionist" abstract thinking common in physical
sciences for extracting mechanistic principles. For example, signal transduction has been
modeled as a network of chemical reactions and mathematically as a system of Ordinary
Differential Equations (ODEs). In dealing with small number of signaling molecules
where fluctuation may dictate the dynamics, stochastic differential equations (SDEs) have
shown success (1-4). Mendelian genetics is essentially a set of probabilistic arguments.
Methods developed in statistical physics for analyzing complex molecular systems and
their macroscopic behaviors can be especially useful, if adapted for appropriate biological
systems.
Among various biological contexts of interest, the adaptive immune system is a
particularly important one. On the one hand, adaptive immunity confers higher
vertebrates the ability to mount pathogen-specific immune response and retain long-
lasting immune memory. On the other hand, autoimmune diseases may arise from the
erroneous functioning of the adaptive immune system. Thus, a better understanding of
the mechanisms underlying various immune responses is imperative for the development
of treatment and prevention strategies for both infectious and autoimmune diseases.
To obtain such understanding, one must overcome many barriers, one of which
results from the multi-scale nature of many phenomena and their underlying
mechanisms. Many processes critical in the functioning of adaptive immunity involve
dynamical events that interact with one another while individually operating on vastly
different time- and length-scales. Using conventional experimental approaches, it is
difficult to examine these diverse time- and length-scales in a systematic and unified
manner. Certain other disciplines, such as the physical sciences and computer science,
have developed a rich repository of analytical tools for multi-scale systems. Thus, an
inter-disciplinary approach toward problems in the immune system has great potential.
While still a relatively recent phenomenon, there have been a number of successful
studies wherein experiments and theory have been fruitfully paired to reveal mechanistic
principles of scales ranging from the molecular to the level of the entire organism (5-8).
Among the array problems in immunology, an especially important one concerns how
T cells are activated in vivo by their cognate antigens. In this complex sequence of events,
dynamical processes operate on vastly different time- and length-scales, anywhere from
molecular signaling events happening within seconds to the proliferation and circulation
of T cells that take place over many days. Only when we examine the coupling of
different time- and length-scales simultaneously do mechanistic insights emerge.
Such an undertaking is fraught with such difficulties, especially were one to rely solely
on conventional approaches. Experimentally, it is typically difficult if not impossible to
track simultaneously both the molecular signaling events within a cell and the cell's
motion. In other words, we usually are not able to observe the "coupling" of different
scales directly in experiments. Computational models, on the other hand, may permit the
exact tracking of all events that individual cells or molecules participate. Statistical
analyses can be performed to identify underlying correlations if any "coupling" exists.
Secondly, the extraordinary complexity of the immune system combined with our lack
of comprehensive knowledge often result in a large combinatorial of possible mechanisms
for any given phenomenon, none of which is significantly more plausible than others. On
what basis can individual mechanisms be validated or rejected? Often, technical
limitations such as the lack of appropriate animal model or biochemistry assay present
enormous barriers for experimental testing, as will be discussed later in Chapter 3. Even
when such experiments are possible, because animal experiments tend to be expensive
and time-consuming, an attempt to screen through all candidate mechanisms
experimentally is, cost-wise, prohibitive. Using efficient implementation of a
computational model, however, the duration of an in silico "experiment" is typically a
small fraction of a physical experiment. Computational studies can be used to
systematically test and improve candidate mechanisms, the results of which may provide
helpful suggestions for more efficient experimental schemes.
Computational studies of T cell triggering in vivo pose significant challenges. For
example, the need for computational tractability means that the models can only be a
condensed version of the biology they represent. The challenge is to judiciously "pick and
choose" the most relevant biological processes to be incorporated into the model, such
that we can answer the sought-after questions without compromising computational
feasibility. Such models have the additional advantage of being more likely to produce
experimentally testable hypotheses. In the case of a multi-scale system, however, the
balance of biological relevance and computational feasibility is even more daunting. Here,
one may need to tailor different computational treatments for disparate time- and length-
scales (e.g. deterministic vs. stochastic). Due to these barriers, multi-scale computational
models have not seen much application in immunology.
In this thesis, I will discuss two such computational frameworks I have developed for
examining T cell triggering in vivo. Besides providing new mechanistic insights, the multi-
scale features of these undertakings constitute new additions to the toolbox for studying
the immune system. These computational frameworks are versatile and can be easily
adapted for other similar biological systems. My goal in this endeavor is thus not only to
improve our understanding of T cell triggering in vivo, but more importantly to expand
our repertoire of modeling techniques for multi-scale biological systems in general.
Guided by these objectives, this thesis is organized as follows. After a background
discussion and overview of the scope of this thesis, in the remainder of Chapter 1 I will
provide a brief introduction on the immune system with the specific focus on how
dynamical events on vastly different time- and length-scales collectively enable various
important immune functions. Chapters 2 and 3 will both examine how T cells detect
antigen in vivo but with different focuses. The study in Chapter 2 predated that in
Chapter 3 and was in close synergy with a set of microscopy experiments that imaged
dynamics on the cellular- and tissue-level. The corresponding model was developed for
the same time- and length-scales. After a separate study from our lab (9) discovered a
hysteretic signaling module in the TCR signaling network, I was able to incorporate these
newly delineated intracellular dynamics and expand the earlier model to combine the
simulation of stochastic molecular signaling network with simultaneous cell migration.
Results from this study have motivated new experiments. Furthermore, this multi-scale
computational framework can be generally applied to study other biological systems
where cell migration dynamics are coupled with intracellular or inter-cellular signaling.
Chapter 4 will first provide a summary on the investigations completed so far, then
describe a third problem, which entails the integration of dynamics from a much longer
time- and length- scale. Some initial modeling and results will also be presented, as the
basis for discussion of possible future directions.
Various theoretical and computational analyses have been conducted for each of these
studies. For the study in Chapter 2, a lattice-based Monte Carlo simulation was developed
to describe the isotropic diffusive motion of T cells. Partial Differential Equations (PDEs)
were used to carry out a mean-field analysis and produce some interesting mechanistic
insights. For the study in Chapter 3, I expanded upon the original Monte Carlo simulation
to allow for efficient simulation of diffusion in free space, instead of a lattice. This
migration model was then adapted to simultaneously simulate intracellular signaling by
incorporating a fast implementation of the Gillespie Algorithm, Stochastic Signaling
Compiler (SSC). Probabilistic analysis of the numerical results was performed by way of a
Markovian probability analysis. For the preliminary investigation of the problem
presented in Chapter 4, a system of Delayed Differential Equations (DDEs) were
implemented using MATLAB@.
1.2 The adaptive immune system on many scales
The immune system consists of innate and adaptive immunity. Innate immunity provides
a highly effective first defense against invading pathogens by recognizing generic
molecular patterns presented by pathogens. Such recognition is not pathogen-specific,
and can be evaded by some bacteria and all viruses via mutation. Jawed vertebrates have
the additional defense of adaptive immunity, which responds to invading pathogens in a
pathogen-specific manner, and maintains a memory of past infections, which allows for a
faster and more efficient response should a second infection occur. In this section, I will
provide a summary of some important processes pertinent to an adaptive immune
response. The focus will be on processes that are investigated in this thesis. They are
organized into different time- and length-scales, from the smallest to the largest. I hope to
not only show the biological background of this thesis, but also highlight how closely
integrated these dynamical events are, despite their disparate scales. I also hope to
underscore the importance of a multi-scale perspective toward understanding the
adaptive immune system.
1.2.1 The molecular level
T cells are the central orchestrators of cell-mediated or adaptive immunity. They are
responsible for the detection and defense against invading pathogens, or antigens (Ag).
They bear specialized T cell receptors (TCR) on their surface, which can interact with
cognate peptide major histocompatibility complex (pMHC) on the surface of antigen
presenting cells (APCs). Most of the APCs are dendritic cells (DCs).
Typically, there are -10s MHC molecules on the surface of an APC. The vast majority of
these MHC molecules present endogenous peptide fragments, which, bar the case of
autoimmunity, do not trigger adaptive immune responses (10). Irvine and coworkers
have shown that as few as 1 antigenic pMHC could stimulate TCR for Ca2+ flux, and -10
pMHCs can elicit the formation of the immune synapse and sustained signaling (explained
below) (11).
Upon detection of cognate Ag, TCRs initiate a cascade of signaling events that
ultimately lead to both short-term and long-term immune responses. Ca2+ ion flux due to
TCR signaling can appear within 1-2 minutes after TCR-pMHC engagement (11). TCRs,
co-receptors and adhesion molecules such as LFA-1 may co-localize to form a highly
structured synapse at the interface between the two interacting cells. Other early
markers, including CD69 and CD25, of T cell activation are also upregulated on T cell
surface rather quickly. This implies that the signal generated on the cell surface upon
TCR-pMHC binding propagates through the extremely complex intracellular signaling
networks very rapidly. Indeed, many steps in the signaling network involve a few
molecules interacting over extremely short time-scales.
Other essential molecular signaling events include the change in adhesion properties
and cytokine secretion, both of which can happen on the time-scale of minutes.
Interleukin-2 (IL-2) is one of the earliest cytokines to be produced by activated CD4+ T
cells (see chapter 4 for more details). The mRNA transcripts for IL-2 can appear within
10 min of CD4+ T cell activation. Changes in T cells' surface adhesion are thought to
result from integrins interacting with their ligands, most notably LFA-1 and its ligand
ICAM. Though unsolved questions remain regarding how TCR signaling rapidly
upregulates the affinity of LFA for ICAM, experiments have shown that this upregulation
can happen within 1 second of LFA activation (12).
1.2.2 The cellular and tissue level
Many dynamical events at the molecular level culminate in changes in T cells' behaviors
or properties at a higher level. Here I would like to highlight the characteristic scales at
the cellular and tissue level to contrast those discussed previously.
At the cellular level, TCR signaling leads to re-organization of the cytoskeleton, which
then causes cell morphology to change from an amoeboid shape to one that is more
spherical. T cells' motility pattern thus switches from a rapid, diffusive motion
punctuated with transient interactions with DCs to one where stationary T cells engage
DCs for long periods of time. Interactions between adhesion molecules such as LFA-1 and
ICAM are instrumental in facilitating these changes at the cellular level.
The distance over which a DC can interact with a T cell can be large, since DCs extend
out long dendrites, some as long as 20gm (more than one cell-length), which sweep
around the cell body, in an attempt to capture T cells as they pass by (13). The
interactions between a T cell and a DC can be as brief as a few minutes or long and stable
(e.g. (14, 15), see Chapter 2 for more details).
Another important cellular event during T cell activation is cell proliferation. A
multitude of signaling events leads to the production of new cellular materials and the
division into two daughter cells. At the peak of proliferation, an activated T cell can divide
once every 6h. The division itself takes roughly half an hour. The polarity of this division
has been linked to the lineage commitment of daughter cells (16). After the primary
immune response, most activated T cells undergo apoptosis, which, again, is due to the
transduction of apoptotic signals.
1.2.3 The tissue level
Adaptive immunity takes place in many different tissues. Here I will restrict my
discussion to the ones most relevant for T cell triggering. T cell triggering occurs in
secondary lymphoid organs (SLO), such as lymph nodes (LN), spleens and Peyer's
patches, with LN being the most important site of defense battles. The most central
function of LN is to provide an interface between the lymphatic and blood circulation to
facilitate immune surveillance. Lymphatic and blood circulation carry extracellular fluid
and lymphocytes, respectively, to the LN. In this manner, soluble or cell-associated Ags
are collected from all over the body and presented to the T cells to initiate immune
responses. To accommodate such function, the LNs have highly organized and specialized
internal architecture. It is estimated that a typical LN contains -109 cells per gram mass,
around 45% of which are T cells, 25% B cells and the remaining 15% mostly DCs. In
other words, there are ~ 108 CD4+ or CD8+ T cells and 107 DCs per gram mass (17).
Note that the relative abundance of a particular clone of T cells will increase significantly
due to vigorous proliferation in the primary response. Within 6-8 days, CD8+ T cells may
increase in number by 15,000-fold (18). These cells migrate at different speeds and
interact with each other both directly via physical contact and indirectly via cytokines and
chemokines. The flow rate into and out of LN is about 106 cells per hour (17). Each T cell
has only about 20-24 hours of residence in a LN to search for cognate Ag, otherwise it
leaves without being activated (19). In mice LN, the frequency of a particular TCR clone is
about 50 cells out of 5 million cells in total (20). Combining this low precursor frequency
with the constraint on search time, the detection of Ag becomes a "needle in a hay stack"
problem (see Chapter 2).
Finally, the presentation of cognate pMHC by DCs may also change, typically over the
time-scale of several hours, up to 1 day. Earlier studies have shown that agonist peptide
may dissociate from pMHC. Measured half-lives range from 2 to 7 hours (21). After
acquiring antigenic materials, DCs take about 18h to circulate into the LN (14), where
they may take an additional several hours to become fully mature, which allows for more
effective pMHC presentation to T cells (22). The significance of these processes will be
discussed in Chapter 2 and 3.
1.2.4 The organism level
The various aspects of adaptive immunity are integrated at the organism level, though
during T cell triggering, most activities are restricted to within the site of Ag detection,
namely the SLOs. Here, I will briefly touch upon the events that occur after T cell
triggering in SLOs, and comment on their implications in the context of this thesis.
Activated T cells proliferate vigorously for several days before exiting via blood
circulation. This is partly due to the changes in chemokine receptors on the surface of T
cells, which are altered as a consequence of T cell activation. The new combination of
homing receptors direct activated T cells away from SLOs and toward peripheral tissues,
where they perform effector functions for days to come. After the primary response,
while most effector cells die, a small fraction remains as memory cells, which can be
activated much more rapidly should a later infection by a similar pathogen occur. Such
immune memory can persist for many years. What are the connections between T cell
triggering and these events that occur much later in time and much further away from the
site of T cell triggering? There is evidence that suggests the commitment toward either an
effector or memory lineage takes place during the initial triggering of T cells (16, 23, 24).
Thus, early events that occur locally and rapidly can have far-reaching consequences.
I hope this brief introduction has highlighted the plurality of time- and length-scales
involved in this thesis. The more we can approach adaptive immunity from a global
perspective, the better we can appreciate its intricate orchestration, but the level of
difficulty also exponentially increases. Statistical physics and chemical kinetics have
unique advantages in addressing such difficulties, as they have extensively dealt with
macroscopic observables that are governed by collective microscopic events. In the next
3 chapters, I will describe 3 instances of their application to immunology.
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Chapter 2
How antigen quantity and quality determine T-cell decisions in
lymphoid tissues
As a first step in a multi-scale examination of T cell triggering in vivo, I studied how the
quantity and quality of antigen present in lymphoid tissues may affect T cells' decision to
stop on the surface of their cognate dendritic cells and become activated. This question
served as a good starting point for a multitude of reasons. First of all, it does not require
the detailed knowledge on the molecular signaling network involved in T cell triggering,
thus the implementation is relatively simple. Secondly, a wealth of intravital imaging data
was available to guide the development of a good model for T cell migration. In
particular, Sarah E. Henrickson and Uli von Andrian at Harvard Medical School studied a
highly analogous experimental system while the in silico model was being developed.
Synergy between our experimental and computational approaches was greatly
productive. The collaboration is covered in this chapter, as well as two publications (1, 2).
2.1 Introduction
Recent multiphoton and confocal microscopy experiments have produced vivid images of
the migration of T cells in lymphoid tissues during antigen recognition (3-17). For both
CD4 and CD8 T cells, the motility characteristics change with time. Initially, T cells move
quite rapidly upon entering the lymph node (LN). In the presence of cognate antigen,
after a few hours, antigen-specific T cells slow down and make stable contacts with
dendritic cells (DCs) presenting cognate antigen (3, 8-12, 14, 15). In CD8 T cells, these
two stages of different T cell motility have been labeled "phase one" and "phase two"
behavior (9). It seems reasonable to assume that phase one corresponds to a period
during which T cells "hunt" for antigen, whereas phase two is a period of time required
for signaling processes that result in full commitment to activation (9, 11). An important
open question is which factors determine the time required for the transition from phase
one to phase two? This is important as this decision predicates T cell activation and the
initiation of an immune response.
Several hypotheses could be considered to address this question. One is that T cells
may go through such motility changes by default (9). This hypothesis implies that all
antigen-specific T cells in the LN would transition into phase two synchronously, and that
the time at which this happens should be independent of antigen dose or stimulatory
potency. However, it seems more likely that this transition is linked to signaling events
stimulated by interactions of T cell receptor molecules (TCR) on the surface of T cells with
cognate, peptide-loaded major histocompatibility (pMHC) molecules expressed on DCs.
This suggests a second hypothesis: the transition from phase one to phase two is
influenced by the nature of cognate pMHC ligands, their expression levels on DC surfaces,
and the number of DCs in the LN that bear cognate antigen. In this case, the time at which
a particular T cell transitions from phase one to phase two type behavior depends on its
history of interactions with DCs, which is stochastic in nature but also have a relatively
broad distribution over time. We also explored the consequences of summation of
multiple interactions with APCs on the duration of phase one. We have studied how all of
these variables collectively define the duration of phase one using computer simulations
and theoretical calculations.
Migrating T cells stochastically encounter DCs bearing antigen, which, in turn, can
stimulate a stop signal with some probability thereby leading to sustained contacts. We
find that the average antigen dose per DC, the number of DCs bearing antigen, and the
characteristics of the TCR-pMHC interaction determine the mean time required for a
transition from phase one to phase two. Our results on how antigen dose per DC and
numbers of antigen bearing DCs affect the duration of phase one are in excellent
agreement with experimental observations described by Mempel et al. (9) and
Henrickson et al.(18). Importantly, theoretical analyses of the computational and
experimental results provide a conceptual framework to understand how the
consequences of changing one measure of antigen dose or type on the duration of phase
one depend on the values of other related quantities that also play a role in T cell
activation in vivo. We find that an interplay between two time-scales which encapsulate
the effects of antigen characteristics and amount is important. One of the time-scales is
the half-life of the pMHC complex, which characterizes its stability. The other time-scale
characterizes typically how long it takes for a productive T cell - DC encounter to occur.
Results for the duration of phase one obtained by varying diverse measures of antigen
quantity and type collapse onto one consolidated "master" curve when antigen quality
and type is measured by the ratio of these two time-scales. The mechanistic principle
embodied in this result should help guide future experimentation, because it shows how
the effect of changing one variable is influenced by other relevant parameters.
2.2 Model and simulation method
2.2.1 Model development
Beltman et al. (19, 20) have studied T cell migration in a realistic representation of the
densely packed physical environment of the LN using a computational method based on
the cellular Potts model. These simulations faithfully reproduce many experimentally
observed quantities that characterize T cell motility, such as velocity distributions, T
cell/DC scanning frequencies, etc.. These studies also suggest that changes in velocity
distributions observed upon transition to phase two type behavior require strong
adhesion and stop signals from cognate DCs. Quantitative recapitulation of the
experimental and computational facts regarding T cell motility (e.g., velocity
distributions) is not the purpose of our in silico studies. While our investigations are
closely synergistic with experiments (18), our purpose is to glean qualitative mechanistic
principles that determine the duration of phase one. Specifically, we aimed to elucidate
how variables such as cognate pMHC dose per DC, -number of cognate DCs, stability of
pMHC, etc., influence this duration. This goal guided the choice of the model that we
simulated and analyzed.
We use a lattice representation of the space corresponding to the LN (Fig. 2.1) with
periodic boundary conditions in which the edges of the box (e.g., left and right or top and
bottom) are essentially pasted together. Thus, for example, when a cell exits the box on
the left it reappears on the right. This enables simulation of the large spatial extent of the
LN (-1 mm 3) with no collisions of T cells with the faces of the simulation box. Each type
of cell (e.g., a T cell or a DC) can occupy one of the lattice sites. Motile cells can hop from
one lattice site to a neighboring one. This discrete, rather than continuous,
representation of space dramatically reduces the computational power required to
simulate the effects of specific parameters characterizing antigen dose and type on the
duration of phase one. The lattice representation does not lead to artifacts as long as the
properties of interest are manifested on long time and length scales (21) (and one other
condition noted later is met). As we focus on the transition from phase one to phase two
behavior, which occurs on a time-scale that far exceeds the microscopic time associated
with cell motion between lattice sites and signaling events during transient T cell - DC
encounters, a lattice representation is appropriate. We also note that while our stochastic
simulations allow us to examine the important effects of fluctuations, the average values
of the simulation results agree with those obtained from a mean field treatment that does
not use a lattice representation. Therefore, for the qualitative results that we seek, the
lattice representation seems adequate.
T cells 0 Cognate DCs 0 Noncognate DCs
Figure 2. 1: Lattice representation of the volume in the LN that is subject to computer
simulations. Cognate and noncognate DCs and T cells are shown schematically.
The lattice is 30x30x30 units in size. Only antigen-specific T cells were explicitly
simulated to obtain the results shown here. Simulations wherein non-cognate T cells
were included showed that the results were affected only when there were vastly many
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non-cognate T cells, at lower levels the results are unaffected by their presence (see
Appendix).
The T cells can be either motile or arrested. Intravital microscopy data suggest that T
cells move in a directed fashion over distances of the order of 10 gm before changing
direction randomly (4, 6, 9-11, 22). On large length and time-scales, the statistical
features of the motion are those characteristic of a random walk. Experiments also show
that the average speed of migrating T cells is on the order of 10gm/min. In view of these
facts, we consider the spacing between points on the lattice to be 10gm and the
elementary time step to be one minute. This means that our simulation box is
approximately 300gmx300tmx300gm in size. Our simulation results apply also to other
choices of the average directional movement (e.g. 20gm), because such changes would
require a simple rescaling of the lattice dimension (20gm instead of 10gm). The
simulation period of 1440 elementary steps corresponds to a 24-hour residence period of
T cells in the LN (23). This simulation period is chosen because if T cells do not get
activated and up-regulate CD69 (24), they migrate out of the LN after approximately 24
hours (23).
We consider two types of DCs, those bearing cognate pMHC ligands (cognate DCs) and
those that do not display these molecules. Since intravital multiphoton microscopy
results have shown that DCs are far less motile than T cells (6, 7, 10), in all our
simulations the DCs are immobile. This will not affect qualitative results because the
motion of DCs simply affects the frequency of T cell - DC encounters. It can be rigorously
proven that in a system where the DCs are immobile, the T cell - DC encounter frequency
equals that where they are allowed to move, if the motility coefficient characterizing T cell
motion is taken to be the sum of that for T cells and DCs. As we discuss later, the
encounter frequency does not limit the transition from phase-one to phase-two behavior,
thus accounting for the slow movement of DCs is not important for the issues we study.
Therefore different choices and/or random distributions of T cell speeds (e.g., centered
around 10gm/min) will also not have an important effect.
A larger number of non-cognate DCs create more barriers for T cell migration, resulting
in a lower T cell motility coefficient. Thus, we adjusted the number of non-cognate DCs to
obtain a motility coefficient consistent with the experimentally measured values (9-11).
A motility coefficient of 11gm 2/min was obtained with 3000 non-cognate DCs placed in
the lattice. The numbers of cognate DCs and T cells span a range of values (from 100 to
1000 for DCs, 250 to 750 for T cells) in our simulations in order to examine their effects
on the time at which a transition from phase one to phase two behavior occurs.
Henrickson et al. measured that a typical LN imaged in the experiments is
approximately 1mm 3 in volume, of which roughly 5-10% is the volume where relevant
migration takes place. They also estimated that 300 cognate DCs are scattered therein,
resulting in a density of 3000-6000 cognate DCs per 1mm 3 . Since our entire lattice is
scaled to be 0.027mm 3, the appropriate number of cognate DCs in the lattice should be on
the order of 100 cells. Most of our simulations have been carried out with 100 cognate
DCs and 500 cognate T cells, and qualitative results do not change upon varying these cell
counts (see Appendix).
We have carried out simulations wherein the total number of DCs and T cells occupy as
much as 50% of the available volume, which is lower than the fraction of space occupied
by cells in a normal LN (25, 26). Simulations with higher densities of cells become
computationally intensive. If we explicitly simulated all the non-cognate DCs and T cells,
the following artifact of the lattice representation (which makes the simulations
computationally tractable) would render the results less meaningful. Since we model T
cells as hard objects that cannot occupy sites already inhabited by other T cells, including
a very large number of non-cognate T cells and DCs would lead to a "jamming" of the
lattice, in which case no cell would move. In reality, of course, space is continuous and T
cells are deformable, and so such a jamming does not occur in the LN. Our goal is to
determine qualitative mechanisms via which T cell motility is influenced by cognate
pMHC. These qualitative mechanisms should not be affected by using fewer cells so that
the jamming artifact is not manifested.
At the beginning of a simulation, all cells are placed randomly on the lattice, and all T
cells are motile. T cell motion is simulated using a Monte-Carlo algorithm (see Simulation
Method). In short, a T cell is picked randomly, and an attempt is made to displace it in a
random direction. If the chosen target site on the lattice is not occupied by another T cell,
then the T cell moves to the new location. T cells are allowed to occupy the same site as a
DC because they have been observed to sit on the surface of DCs and scan for antigen (5,
6, 8-12, 15). In addition, DCs have been observed to extend out multiple dendrites from
their center of mass and these protrusions are longer than 10gm (9, 10). Since a DC can
interact simultaneously with several T cells, and encounters between DCs and T cells can
occur simultaneously at several dendrites (6, 9-11), in our model, T cells at the 6 lattice
points surrounding a DC can simultaneously interact with it and scan for antigen. Along
with the fact that T cells can co-occupy the same lattice point as a DC, in principle, a large
number of T cells (exceeding 6) are allowed to scan a DC simultaneously, as observed in
experiments. Experiments have also shown that the brief contacts during phase one last
for about 3 minutes (4, 6, 9-11, 27), which we model by introducing a scanning time equal
to 3 Monte-Carlo steps (this corresponds to approximately 3 minutes). T cells that
encounter a DC do not move until this scanning time period has elapsed. Varying the
length of scanning time does not alter the results qualitatively (see Appendix).
During the scanning period, interactions between the TCR and pMHC on DCs as well as
integrins, co-stimulatory molecules, and cytokines result in intracellular signaling events
that could lead to a stop signal (28). It remains an open question whether T cells can
integrate signals from multiple serial encounters with cognate DCs (15, 17, 27, 29), or a
threshold level of signaling must result from encounters with a single DC (8, 30-34). We
consider both scenarios, one in which T cells can integrate signals from serial encounters
with DCs, and in the other, any signaling resulted from a T cell-cognate DC encounter is
"forgotten" instantly after the T cell disengages.
In the latter situation, if a T cell encounters a cognate DC, signaling can lead to a stop
signal with a probability equal to k (implemented as part of the Monte-Carlo algorithm
described below). This probability is related to the characteristics of the TCR-pMHC
interaction and the level of pMHC expression on the surface of the DC. Our model for T
cell migration must be linked to molecular signaling models (e.g. (35-40)) in order to
properly link k to these quantities, which reflect antigen quality and quantity. While such
a sophisticated multi-scale model is under development, in the present study, we adopt a
simpler approach. We model the relationship between k and antigen concentration by a
sigmoidal curve, which exhibits a threshold antigen concentration above which k is large
and below which k is small (Figure 2.2). This shape is chosen because experimental
results for markers of T cell signaling/activation exhibit such dose-response curves (e.g.
(36, 41)). The value of k is zero when the antigen concentration is zero, and approaches
one for large values of the antigen dose. A function with a sigmoidal shape was used to
interpolate values of k between these asymptotes (see section 2.2.2 Simulation methods).
Different TCR-pMHC-binding characteristics alter the threshold concentration defined by
the sigmoidal curve and its sharpness. While the results in the main text are for a
particular choice of the location and sharpness of the threshold of this sigmoidal curve,
we found that changing the values of these variables only results in quantitative, rather
than qualitative, differences (see Appendix).
To study situations where T cells can integrate signals from multiple DCs, the
probability of generating a stop signal (k) upon a particular T cell - DC encounter is
modeled to depend upon the history (or experiences) of that particular T cell as it
migrates through the LN. The specific way in which k depends on history in our
simulations is described in the context of our results.
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Figure 2. 2: Probability for T cells to receive a stop signal upon encountering a cognate DC (k)
plotted against the concentration of pMHC on DCs after pulsing with peptide prior to adoptive
.... ... ...  ..  ........ ................ .
transfer. Original mapping (green circles) corresponds to the mapping used for the results presented
in the text, as described in Materials and Methods. To demonstrate how such mapping can be varied,
two alternatives are shown. Alternative 1 (orange triangles) is a mapping with the pMHC threshold
moved to the right (i.e., a higher initial loading of pMHC is needed for the same probability of
stopping), while alternative 2 (purple circles, dotted line) maintains the original threshold location
but exhibits a sharper response. As a consequence, k increases more sharply as the initial pMHC
concentration is increased.
Most intravital microscopy experiments are conducted several hours after antigen
(peptides targeted to DCs, protein and adjuvant injected subcutaneously, or adoptively
transferred antigen pulsed DCs) is injected into mice (3-16) and the transition from phase
one to phase two type behavior can occur several hours after T cells enter the LN (9, 11,
15). Thus, an important variable is the time-scale over which cognate peptides are lost
from MHC molecules. As we shall see, this variable can have an important effect on the
time corresponding to a transition from phase one to phase two. This effect is studied in
the computer simulations by varying the characteristic time-scale, ', which describes the
first order dissociation process via which the antigen concentration on DCs decreases
over time.
2.2.2 Simulation methods
For each Monte-Carlo move (42) a random integer drawn from a uniform distribution of
integers from 1 to N (where N is the number of T cells) is used to pick a T cell, and an
attempt is made to displace it to a neighboring lattice point in a randomly chosen
direction. If the chosen T cell has not yet received a stop signal, and the proposed location
is not occupied by another T cell, the T cell moves to the new location. Otherwise, the
move is rejected and the T cell stays in place.
A T cell-DC encounter occurs when a T cell either moves to a lattice point directly
occupied by a DC, or is at the site immediately adjacent a DC site. When a T cell
encounters a DC, it waits (and scans for antigen) for 3 time steps (other values were
tested as shown in Table 2). When a T cell contacts a cognate DC, it can receive a stop
signal with some time-dependent probability, k(t) (see above). In the case without
memory, k(t) is calculated using the pMHC concentration of the DC, p(t), with which the T
cell is currently interacting. Following experimental observations (36, 41), k(t) is related
to p(t), using the sigmoidal function shown below:
4x10-3p(t) p(t) 3
k(t)=] 1.2218p(t) 2 - 1.9878p(t)
734.118 -19.7905p(t)+ p(t)2
1 p(t) > 30
Note that in the above expressions, the time, t, refers to the time after the DCs have
arrived in the LN (e.g., approximately 18 hours after pulsing DCs with peptides and
injection in to animals in the experimental studies of Henrickson et al. (18). To trace back
to the initial pMHC loading on DC surfaces, [pMHC]o, one needs to account for the loss of
peptides during the 18 hours, which can be estimated as [pMHC]o=p(t)exp(-18/r), where 'r
is the time-scale of pMHC loss in units of hours, and we have used values for treported in
the caption of Figure 3. Changing the values of the constants in Eq. 2.1 represents
changing the TCR-pMHC binding characteristics as it alters the threshold antigen dose
and sharpness of the relationship between k and antigen dose. We also performed
simulations with either the threshold location or sharpness altered (see Results and
Appendix for details).
In the case without memory, at the beginning of each elementary time step,
p(t) and k(t) are updated. When a T cell - cognate DC encounter occurs, a uniform
random number (r) between 0 and 1 is generated and compared with the current value of
k(t). If r k the T cell receives a stop signal. If r > k, the T cell waits one step and repeats
the activation attempt in the next step, with the same value of k as in the previous step.
This procedure is chosen because we imagine that pMHC loss from the T cell - DC contact
zone is unlikely. If no arrest occurred after 3 steps have elapsed, the T cell starts
migrating again. T cells in contact with non-cognate DCs cannot receive a stop signal. We
have also examined the case in which peptide loss is allowed in the contact zone, as well
as the scenario where it is only possible to deliver a stop signal during the first scanning
step. In both cases, the qualitative results (see Appendix) do not change.
This simulation protocol is modified slightly to incorporate signal integration, i.e. the
"memory" effect. The details will be discussed in the next section along with relevant
results.
Table 2.1: Definition of symbols used to represent important quantities.
Symbol Description Units
D Motility coefficient
Probability of a stop signal upon a T cell-DC
K encounter; depends upon TCR-pMHC binding
characteristics and concentration of antigenic pMHC
per DC
p Concentration of cognate-pMHC on DC surface
t Time
p Density of cognate DCs in the LN
gm 2/min
min -1
Number / DC
Hours
Number /Im 3
Characteristic time-scale for peptide dissociation
from MHC groove
Average time for T cell to encounter a cognate DC
via motion characterized as a random walk
Characteristic time required for a productive T cell -
DC encounter; depends upon TCR-pMHC binding
characteristics, number of cognate DCs in LN, and
pMHC concentration on DC surface
Hours
Hours
Hours
2.3 Results
We have considered situations where T cells can and cannot integrate signals from serial
encounters with DCs. We begin by reporting results from simulations and theoretical
calculations where naYve, recirculating T cells do not exhibit a "memory" of past
encounters with cognate antigen-bearing DCs in the LN.
2.3.1 Ag dose and quality determines the transition from phase one to phase two
In our simulations, antigen quality and quantity are determined by three variables: (1) the
initial concentration of cognate pMHC ligands on DC surface and their TCR binding
characteristics, which determines the probability (k) that a particular T cell - cognate DC
encounter will result in a stop signal; (2) the stability of complexes formed between the
cognate peptide and MHC proteins; (3) the density (or number) of DCs in lymphoid tissue
that present these ligands.
The amount of cognate pMHC on DC surfaces, and hence the value of k, changes with
time as peptides dissociate from the MHC groove. The stability of the pMHC complex is
described by the parameter -r, which is the time associated with peptide dissociation from
the pMHC complex. This parameter, along with the initial concentration of antigen loaded
onto DCs before adoptive transfer, determines the antigen concentration displayed on DC
surfaces at any given time. The density (related simply to the number) of cognate DCs in
the LN is described by a single parameter (p).
Figure 2.3a and 2.3c show that the fraction of T cells arrested before the exit time (24
hours) has elapsed depends on antigen quality and quantity. The fraction of T cells
arrested increases as the initial antigen loading and the density of cognate DCs are
increased. This is because a higher density of cognate DCs (e.g. 300 vs. 100 cognate DCs
per lattice) increases the probability of T cell - cognate DC encounter, while higher
antigen concentration on DCs corresponds to a higher probability for the T cell to receive
a stop signal (i.e., higher k). Varying the exit time between 10 and 27 hours led to barely
any change in the results (see Appendix for discussion). Note also that since the arrested
cells are the ones most likely to commit to full activation (28), late activation markers (e.g.
proliferation) likely change in ways that parallel the changes in the fraction of arrested
cells; thus, the fraction of arrested cells can be considered to be a measure of late markers
of activation.
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Figure 2. 3: Antigen dose and type determine the transition from phase-one- to phase-two-type behavior.
Computer simulation results for the fraction of T cells that have been arrested before the exit time has
elapsed (a and c) and the inverse of the mean duration of phase one (b and d) as a function of the
concentration of pMHC on DCs prior to adoptive transfer into recipients. The duration of phase one is
defined as the time required for 50% of the T cells to make sustained contacts with DCs, as described in
the text. The relationship between the units of concentration on the abscissa of the graphs and the
concentrations of peptides used to pulse DCs in experiments carried out by Henrickson et al. (22) is
described in the text. If a transition to phase two does not occur prior to exit, the duration of phase one is
taken to be infinite, in which case the inverse of the duration of phase one is zero, as seen in panels b
and d. Results for two pMHC ligands, characterized by different half-lives of the pMHC complex, are
shown. The values of the half-life that were used are approximately 6 h and 2.35 h, since that roughly
corresponds to the experimentally determined pMHC half-lives for the M peptide and C peptide,
respectively (22). These peptides are the natural (C) and an altered (M) peptide ligand for the P14 TCR
transgenic system. One hundred cognate DCs (a and b) or 300 cognate DCs (c and d) are analyzed.
The results displayed in Figure 2.3b and 2.3d make direct the connection with the
experimental observations of Henrickson et al.(18). They observed the T cell migration
patterns in LNs containing adoptively transferred DCs pulsed with various antigenic
peptides ex vivo. Henrickson et al. define the time corresponding to the transition from
phase one to phase two as that at which some large fraction (e.g., 50% of the T cells) are
no longer motile (i.e. the median times of interaction between antigen-specific T cells and
peptide pulsed DCs are greater than 30 minutes in a 60-minute observation period). T
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cells do not transition to phase two in a synchronous manner. The duration of phase one
type behavior for individual T cells in each of our in silico trajectories varies widely (from
minutes to hours), especially at the threshold concentration of pMHCs required to induce
a transition to phase two. In experiments too, different T cells stop at different times.
Similarly, because of the stochastic nature of this process, the duration of phase one
observed by Henrickson et al. also differs from one experimental realization to another,
fluctuating around some average value. Similar behavior is also captured in our
simulations. In both our simulations and in the experiments, an average value of the time
at which a large fraction of T cells are arrested is reported. This time is representative of
the behavior of the population of T cells, but does not imply synchronous behavior for
every T cell.
Figure 2.3b and 2.d show how the average time at which 50% of the T cells are
arrested depends on the initial value of antigen concentration on DC surfaces and the
density of cognate DCs (e.g. 300 vs. 100 cognate DCs per LN). The shape of these curves is
strikingly similar to that reported by Henrickson et al. for the dependence of the time of a
transition from phase one to phase two on the peptide concentration used to pulse DCs ex
vivo. Besides the two values of DC loadings displayed in Figure 3, several other values
were also tested and led to no qualitative difference (see discussion in Appendix).
One of the pMHC ligands studied by Henrickson et al. (18) is called the "M-peptide".
This is an altered peptide ligand for the P14 TCR transgenic system, wherein T cells
recognize a peptide from lymphochoriomeningitis virus (LCMV, KAVYNFATC is the
natural peptide and KAVYNFATM is the "M-peptide"). They report that for DCs pulsed
with 100pM of M-peptide, a transition to phase two was not observed. Pulsing
concentrations of 200pM resulted in phase-two-type behavior after 6-8 hours, and all
higher pulsing concentrations led to a phase one that lasted 2-4 hours (18). Thus, this
experimental data seems to exhibit the thresholding (with 200 pM as the threshold) and
asymptotic behavior observed in our simulation results. The thresholding behavior
results from the nature of the dose-response curve characterizing T cells signaling (Figure
2.2).
The stability of pMHC determines the amount of cognate pMHC left on the DC surface
at various times after adoptive transfer. Consequently, the time-scale r characterizing
pMHC dissociation influences T cell migration and activation by affecting how the
probability of productive signaling (k) varies over time. Two values of r differing
approximately by a factor of 2 (3.4 and 8.7 hours, respectively) are considered in Figure
2.3. These values were chosen because they correspond to the stability characteristics of
the M- and C-peptide in the experimental studies of Henrickson et al.(18). We also
explored a range of rvalues between 100 to 800 min, the qualitative behavior parallels
those shown in Figure 2.3 (see discussion in Appendix). Our results show that, while
keeping all other parameters the same, values of r that differ by a factor of 2 can result in
a substantial difference in the fraction of T cells arrested before the exit time has elapsed
(Figure 2.3a and 2.3c). Equivalently, the less stable peptide requires a longer time to
transition into phase two. Ligand concentrations that result in a transition to phase two
for the M-peptide would not lead to such a transition for the C-peptide, as observed in
experiments (18).
However, there are some subtleties. For example, at the threshold concentration
required to observe a transition to phase two, the duration of phase one obtained from
simulations is roughly the same for the M- and C-peptide (note, however, this threshold
concentration is much higher for the C-peptide), if TCR binds both pMHC with the same
affinity. In reality, however, the C-peptide could bind TCR slightly more weakly compared
to the M-peptide. This can be modeled by moving the threshold in the relationship
between k and antigen concentration to higher concentrations. We could establish that
while such changes do not alter our conclusions in qualitative ways, the results do change
quantitatively (see discussion in Table 2). For example, shifting this threshold by a factor
of 1.5 results in transition times around 9 hours (ranging from 6 to 12 hours) for the C-
peptide, which is consistent with experimental observations (18).
Finally, these results suggest a rough bound on the number of pMHC complex needed
to activate T cells in vivo. Previously, it has been shown in vitro that 1 cognate pMHC can
stimulate Ca2+ flux in a T cell, and -10 pMHC complexes can trigger the formation of
synapse between a T cell and an APC (43). The requirement in vivo remains unclear.
Henrickson et al. observed that 10 M C-peptide is the minimum pulsing concentration
that could elicit a transition from phase one to phase two (1). Furthermore, a pulsing
concentration oflOM is high enough to replace almost all endogenous peptides in the
MHC grooves of the DCs, thus the initial pMHC loading is roughly 4000 per cell. At 24 h
post-injection (approximately when the transition takes place), there remain about 60
pMHC complexes per cell (pMHC for C-peptide has a half life about 2.36h). Henrickson et
al. also observed that 200pM M-peptide and 10M C-peptide are both threshold dosages
required to elicit a transition from phase one to phase two. Therefore, one can assume
that by the time the transition takes place, the number of M-peptide-pMHC and C-peptide-
pMHC remaining on the surface of DCs should be comparable (-60 pMHC). A reasonable
estimate for the size of a T cell - DC contact zone is about 50m2, or 10% of the total DC
surface area. This implies that -6 pMHC complexes can elicit the transition from phase
one to phase two in vivo. In other words, with a pulsing concentration of 200pM, at the
time of injection, there are approximately 480 pMHC complexes per cell (pMHC
presenting the M-peptide has a half life about 6h). Other factors likely further increases
the probability of peptide loss from the time of DC injection to the transition from phase
one to phase two, therefore this initial pMHC loading is very likely an overestimate. This
simple numerical analysis highlights that the number of cognate pMHC complexes needed
to activate T cells in vivo is very low.
The results shown in Figure 2.3 and corresponding experimental observations (18)
show that antigen quality and quantity determine the duration of phase one.
2.3.2 A consolidated measure of antigen quality and quantity
A common conceptual framework that reveals how antigen dose and type influence the
duration of phase one is obtained by recognizing that the pertinent stochastic processes
are described by distinct average time-scales.
One potentially important time-scale is the length of time required for T cells to
encounter cognate DCs, by effectively random processes. This time, re (the subscript "e"
denotes "encounter"), scales as I , where p is the density of cognate DCs in the LN,
P2/3 D
and D is the T cell motility coefficient which is calculated from experimental results (4, 9-
11). Experimental values of D, p, and the duration of phase one, make clear that 're is much
smaller than the duration of phase one. In other words, prior to exiting the LN T cells
have ample opportunities to encounter cognate DCs. This is consistent with Bousso and
Robey's findings that DCs scan at least 500 T cells per hour in the absence of antigen (6),
and other previous studies (10, 19, 25, 44). Similarly our simulations are carried out for a
range of conditions wherein re (the time required to encounter DCs) is not limiting.
Since different peptides are lost from the DC surface at different rates over time,
another time-scale, the characteristic time for peptide loss (r) discussed earlier, is an
important measure of the quality of antigen. However, how different values of i' affect the
duration of phase one will depend on other key variables. For example, if the half-life of
the pMHC complex is shorter (smaller , less stable pMHC), the effect on the duration of
phase one will depend on the prevailing antigen dose. This is because a higher antigen
dose could compensate for a less stable pMHC. How do we properly compare the effect of
a change in antigen dose (units of molarity) with a change in the peptide half-life (units of
time)? A systematic method to compare the relative impact of changing different
measures of antigen quantity and type (each measured in different units) would be
extremely useful for interpreting and designing experiments.
Assessing the impact of changing the value of one variable while taking into account
the context (values of other pertinent variables measured in different units) is facilitated
by grouping (e.g., as products or ratios) the relevant variables to obtain non-dimensional
quantities (45). The change in the value of such a non-dimensional quantity upon altering
a particular variable properly reflects the relative effect of manipulating this variable.
Our goal is to compare the effect of a change in the stability of the pMHC (a time-scale)
with changes in other measures of antigen type and dose such as TCR-pMHC binding
characteristics, pMHC dose, and number of cognate DCs. To do this, we need to relate
measures of the latter quantities to a time-scale pertinent to the process of T cell - DC
interaction.
As T cells migrate through the lymph node, the number of encounters with DCs (or
time) required to receive a stop signal should depend on the number of cognate DCs,
pMHC per DC, and the TCR-pMHC binding characteristics (represented by the pMHC-to-k
mapping in our model). For example, small values of antigen concentration, cognate DC
number, or half-life of the TCR-pMHC interaction will result in a longer phase one. In
other words, the time required to receive a stop signal (ix) is determined by k and p (the
number of cognate DCs in the LN). Thus, the effect of changing k or pis contained in one
single variable: the time-scale z.
The non-dimensional grouping r/, allows for an "apples to apples" comparison of the
effects of antigen dose and TCR-pMHC binding characteristics with the half-life of the
pMHC complex. If this hypothesis is correct, data obtained from varying diverse measures
of antigen quantity and quality should collapse onto one consolidated master curve if
graphed against the ratio, r/. How can the value of this ratio be obtained in terms of the
individual measures of antigen quantity and quality?
Our computer simulations naturally include stochastic fluctuations which are normal
for all biological systems. Stochastic effects can be important for many phenomena in
molecular immunology (e.g.,(36, 37)). The importance of stochastic effects for the
transition from phase one to phase two behavior is highlighted by the fact that, for
identical conditions, in our computer simulations the duration of phase one varies widely
(over a range of 2 to 3 hours) from one simulation to another. Experiments also show
such variability (18). This is not surprising as for a related problem in physics (survival
probability of particles diffusing in a medium composed of randomly placed sites that can
trap the particles with some probability) the importance of stochastic fluctuations has
been proven in a mathematically rigorous manner (46, 47). Also, the importance of
stochastic effects has been noted by Preston et al. (48) in the context of T cell migration in
lymphoid tissue. Therefore, a computational treatment that a priori assumes that every T
cell undergoes a transition from phase one to phase two behavior at precisely the same
time (the average value of the duration of phase one) is over-simplified. However, such a
mathematical description can be useful in identifying how quantities (such as our time-
scale ratio r/is) depend upon other parameters, and may be satisfactory for obtaining the
mean values of certain quantities.
In such treatment, one writes down a differential equation for the spatio-temporal
evolution of the concentration of the T cells that have not received a stop signal (denoted
as T):
aT = DV 2T - kpT
at E q. 2. 2
T(t=0)=To T(t, ±<o)=0
The spatially averaged solution has the form T/T = exp -pJ k(t')dt'J. In other words,
the number of T cells that have received a stop signal depends only on pfk(t')dt', which
equals -r/rs.
We have carried out computer simulations wherein diverse measures of antigen
quantity and quality are varied to examine whether all the resulting data collapse onto
one consolidated master curve when graphed against r/rs (given by the last formula).
Figure 2.4 shows that all our simulation results (varying initial antigen concentration,
half-life of pMHC complex, fraction of cognate DCs, etc.) collapse onto one consolidated
master curve when the fraction of T cells arrested is plotted against this scaling variable.
This result demonstrates that, since the time required for T cells to traverse the LN is not
limiting, antigen quality and quantity determine the time to transition from phase one to
phase two via an interplay between the time-scales necessary for a productive T cell-DC
encounter (,r) and the time-scale describing the loss of peptides from DCs (r). The
smaller the value of the ratio of these two time-scales (r/s), the longer the time required
for a transition to take place (or equivalently, the lower the fraction of T cells arrested
prior to exit).
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Figure 2. 4: Unifying conceptual framework describing how antigen dose and quality determine the
transition from phase-one- to phase-two-type behavior. Results obtained upon varying diverse quantities
(green diamonds, initial pMHC concentration on DCs prior to adoptive transfer and TCR-pMHC
binding characteristics; blue triangles, the number of cognate DCs; purple x's, stability of pMHC
complexes) all fall on the same consolidated curve when graphed against the consolidated measure of
antigen dose/quality. The latter is calculated as the ratio of two time-scales, namely the time-scale of
pMHC loss from the cognate DC surface (r) and the time-scale for a productive T-cell-DC encounter to
take place (ir ) (see the text for derivation). Results of simulations carried out with or without the
"memory effect" (the ability to integrate signals from serial T-cell-DC encounters) also fall on the same
curve (red crosses). Variations of one parameter and simultaneous variation of two parameters are
considered. The number of cognate DCs is varied from 50 to 500; the initial pMHC concentration is
varied from 3 to 160,000; the half-life of pMHC is varied from 40 min to 16 h; the memory time-scale,
rm, is varied from 0 to 6 h. Increasing the number of DCs, pMHC pulsing concentration, or stability, as
well as the memory time-scale, all lead to a larger fraction of T cells arrested prior to the exit time (24
h). We also applied modifications to the scheme of T-cell activation upon cognate encounter.
Specifically, in alternative scheme 1, instead of being able to receive a stop signal during the entire
scanning period (three steps), the T cell can only receive a stop signal during the first waiting step, i.e.,
immediately after the encounter happens. In the second alternative scheme, the T cell can receive a stop
signal throughout the scanning period but peptide loss is allowed during this time, leading to
progressively smaller values of k. We were able to reproduce the master curve for each modified
scheme similar to the one shown here.
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Henrickson et al (18) observed that a 2-fold decrease in pMHC per DC cannot be
compensated by a 10-fold increase in the number of cognate DCs. Our analyses and
results suggest that this is because the impact of changes in pMHC per DC on 'r/r, exhibits
a threshold, which is because the relationship between signaling efficiency and pMHC
concentration is not linear as discussed earlier (Figure 2.2). On the other hand, the
number of cognate DCs, p, affects this ratio in a linear fashion, as the relationship r/r =
p fk(t')dt' implies. Therefore, a 2-fold decrease in initial pMHC concentration leads to a
much greater reduction in pJ k(t')dt' which can only be compensated by a significantly
larger increase in cognate DC number.
We have also studied situations where there is no antigen loss with time, since peptide
half-lives in MHC class II systems can be very long. Furthermore, in some settings, DCs
could continuously synthesize new pMHC molecules from an intracellular pathogen or
self antigen. In these cases, there is only one relevant time-scale, 'rs, and it equals 1/(k x p)
(note that k, the probability of receiving a stop signal, does not change with time in this
case). Indeed, for these cases, our simulation results obtained from varying the
concentration of pMHC ligands or cognate DC numbers collapse to one consolidated
master curve when time is scaled (divided) by T (data not shown).
2.3.3 Signal integration
The need for signal integration
The fact that the diffusion time is short implies that T cells can efficiently scan many DCs
(6, 10, 19, 25, 44) in a period shorter than the time at which the transition from phase one
to phase two occurs. Previous studies (e.g., Bousso and Robey (6), Miller et al. (10) and
Beltman et al. (19)) show that DCs scan many T cells in a time-scale shorter than the
duration of phase one. However, the transition from phase one to phase two type
behavior requires 6 to 10 hours for the C-peptide (18) and (9). Given that the time
required to encounter a cognate DC is relatively short, why does this transition not occur
at earlier times when antigen dose is higher as fewer peptides have dissociated from DC
surfaces? This is likely because the propensity for generating a stop signal is low from the
very beginning in these systems. This, in turn, suggests that T cells may be integrating
signals from multiple sequential interactions with DCs because of a "memory" that is
intrinsic to the topology of the signaling network. In light of this, we explored the
consequences of such a phenomenon in our computer simulations.
The effects of signal integration
The T cell signaling network has many features that could potentially enable signal
integration. For example, disassembly of membrane-proximal signaling complexes
formed upon interactions with TCR will occur some time after the initial stimulus is
removed. Many feedback loops have also been identified in TCR signaling, including those
involved in membrane-proximal signaling that may be relevant for early events that
result in a stop signal (37, 40, 49). These feedback loops could potentially provide
additional mechanisms for signal integration. Moreover, recent imaging experiments
have examined the ability of T cells to integrate signals derived from successive
encounters (15, 17) and biochemical experiments have suggested the existence of
memory in T cell signaling (29). Finally, while endogenous pMHC are not explicitly
considered in our model, T cell encounters with DCs displaying endogenous pMHC may
also contribute to a "memory", as such interactions could help sustain the effects of
encounters with cognate ligands.
In future modeling and experimental efforts, molecular details of signaling and
migration must be examined simultaneously in order to understand the origin and effects
of memory in detail. At present, however, we adopt a minimalist approach by postulating
that the T cell signaling network has a "memory" of previous encounters with DCs, which
decays with a characteristic time-scale, Tm. Tm is determined by the molecular details of
the signaling network, although, currently the precise origin and values of this time-scale
are unknown.
Specifically, we use the following protocol to simulate signal integration from serial T
cell-cognate DC encounters. A "memory", M (initially equals zero), is associated with each
T cell. Upon the first T cell - cognate DC encounter, k is evaluated using the same
procedure as in the case without memory. Should this encounter be unproductive, the T
cell leaves with a memory of M = k(t), where t is the time for the first encounter with
cognate DC for this T cell. Prior to the next encounter with a cognate DC at some later
time t, the memory decays with some time-scale, rm. Thus M(t') = M(t)exp-- . At
the second cognate DC encounter, the total propensity to receive a stop signal is ket,(t')=k(
t')+M( t') or 1, whichever is smaller. If the T cell does not receive a stop signal, the value of
ktotai is added to its "memory". In this manner, the "memory", M, of previous encounters
may enhance the propensity of a stop signal. This process is repeated upon subsequent
encounters. Since values of rm that are significantly shorter than the time-scale between
successive encounters of a T cell with a cognate DC would have little effect, and values
comparable to the exit time are unlikely, we focused our studies on values of Cm which are
on the order of diffusion time-scale.
Our computer simulations show that initial pMHC concentrations on DCs that would
otherwise not result in a transition to phase two may stimulate sustained contacts when
signal integration is incorporated (Figure 2.5). These results suggest that, even if pMHC
concentrations on DCs in the LN are so low that a single T cell-DC encounter cannot be
productive, integration of signals from serial encounters can result in extended T cell-DC
contacts. This concurs with experimental findings by Henrickson et al. (18) which show a
transition to phase two type behavior under conditions where the antigen density on any
particular DC must be quite small. Figure 5 shows that the effects of signal integration are
more pronounced for less stable pMHC ligands (e.g., the C-peptide in Henrickson et al.).
With the same degree of signal integration (i.e. same decay rate of the signal, m = 160
minutes), the threshold concentration of pMHC required to induce a transition to phase
two is reduced by 52% for the M-peptide and 58% for the C-peptide. This is because,
given the same initial antigen density loaded on to DCs ex vivo, DCs will display fewer of
the less stable pMHC ligands in the LN. The ability to integrate signals from serial
encounters therefore becomes more important for the less stable pMHC antigen. This is
also true for the other values of rm we had examined using computer simulation. With a
larger rm (more persistent "memory"), the threshold concentration required to induce a
transition to phase two can be reduced until a maximum enhancement is reached, beyond
which larger rm no longer reduces the threshold concentration (see Appendix).
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Figure 2. 5: The ability to integrate signals from serial T-cell-DC encounters lowers the antigen dose
required to enable a T cell to transition from phase-one- to phase-two-type behavior. The inverse of the
mean duration of phase one is plotted as a function of the initial pMHC concentration on DCs after
pulsing prior to adoptive transfer. The duration of phase one is defined as the time required for 50% of
the T cells to make sustained contacts with DCs, as described in the text. The way in which signal
integration (memory) is incorporated is described in the text. The time-scale for memory decay is 160
MC steps (or minutes). (a) The half-life of the pMHC ligand is 2.35 h (corresponds to the C peptide in
experiments reported in reference 22). (b) The half-life of the pMHC ligand is 6 h (corresponds to the M
peptide in experiments reported in reference 22). For the results in both panels, 100 cognate DCs were
simulated. The effects of memory are more pronounced for the less-stable pMHC ligand (a). For
example, there is a 58% reduction in the dose required for a transition to phase-two-type behavior in
panel a upon incorporation of memory and a 52% reduction in panel b. These specific values depend
upon the number of cognate DCs, TCR-pMHC binding characteristics, and other relevant parameters.
However, they are almost independent of the time-scale characterizing memory (see the text) if this
quantity exceeds a threshold value.
Note, however, that the shapes of the curves in Figure 2.5 are not altered by
incorporating signal integration. Signal integration simply reduces the time-scale
required for a productive T cell-DC encounter (-r) if a T cell has previously encountered
cognate DCs, and in so doing increases the fraction of arrested T cells. In other words,
signal integration increases the average probability for a stop signal (i.e. the mean value
of k) during the process, as the loss of cognate ligands from the DC surface is ameliorated.
This makes the effective value of r/,r, smaller. Figure 4 makes this point strikingly as all
the simulation results, with and without signal integration, exhibit the same scaling
behavior with respect to the interplay of the important time-scales identified earlier. As
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we note in the next section, the same would be true if memory was conferred by DCs
changing pMHC presentation efficiency upon repeated encounters with cognate T cells.
2.4 Discussions
Understanding the behavior of T cells in lymphoid tissue as they begin to be primed by
APCs is very important as it is a key stage that leads to the detection of antigen and the
mounting of an immune response. Progress in this regard has been aided by the recent
application of multiphoton microscopy technology (50, 51) to immunological questions as
it has enabled spatially resolved in vivo imaging of T cells in real time (3-17). Among the
earliest findings from these studies was that the migratory pattern of T cells (on large
length and time-scales) exhibited the statistical features characteristic of a random walk
(4, 10). Subsequent computer simulations have suggested that this enables efficient
scanning of DCs in LNs (19). Furthermore, recent experiments suggest that the
apparently random (or diffusive) motion may be because T cells follow "tracks" made up
of reticular fibers which span the LN in a statistically random manner, and T cells can
choose different tracks at the intersections (13, 22). Other important findings are that
chemokines can influence the details of T cell motility patterns (52-55), and that T cells
can organize into dynamic "streams" (19).
The dynamic characteristics of T cell migration in LNs varies over time (8, 9, 11, 14,
15). In CD8+ T cells, the first stage (phase one) of rapid scanning (characterized by
random walk statistics) is followed by a second phase wherein T cells make extended
contacts with DCs. In this second phase, presumably, T cells are making sustained
contacts with DCs that are known to be necessary in vitro for full commitment to
activation (e.g. (28)). Therefore, a mechanistic understanding of which factors determine
the transition into phase two, and how they regulate this decision is crucial. Such an
understanding was not available, which was the impetus for this study.
We reasoned that the transition from phase one to phase two results from T cell
signaling stimulated by encounters with cognate DCs. This, in turn, suggested that this
transition is strongly influenced by the quantity and quality of antigen. We have studied
this hypothesis extensively in silico by systematically varying conditions that determine
antigen quantity and quality. Our results are qualitatively consistent with experimental
observations (18), and they provide a mechanistic framework that describes how antigen
dose and type impact the ability of T cells to detect antigen and "decide" to make extended
contacts with DCs.
Increasing the initial concentration of cognate ligands loaded on DCs or increasing the
fraction of cognate DCs reduces the duration of phase one, because both actions lead to a
higher propensity for a productive T cell-DC encounter. If antigen concentration on DCs
and/or density of cognate DCs exceeds a threshold value, the transition from phase one to
phase two occurs very rapidly. This may explain why it is difficult to observe phase one
type behavior in a system characterized by high doses of high affinity antigen on
essentially all endogenous LN DCs (12).
Stability of the pMHC complex itself is also an important variable, with more stably
bound peptides resulting in a shorter phase one. This is because, unlike in vitro
experiments with multiple or single cells or lipid bilayers, a T cell might encounter a DC in
the LN several hours after antigen loading (as in the experiments reported in (4, 8-11,
14)). During this time, peptides are lost from the DC surfaces. The less stable pMHC
complex will thus display lower amounts of cognate ligand, thereby decreasing the
probability of productive T cell-DC encounters.
The power of our theoretical analysis is that it shows that these seemingly unrelated
findings emerge from a single conceptual framework. We have identified three important
time-scales. The first is the characteristic time for T cells to find DCs bearing cognate
ligands, which is rather short for conditions that have been studied previously (6, 8, 10,
44) and by us. Therefore, it is not as important a determinant for the transition from
phase one to phase two behavior. It is worth remarking, however, that in the early stages
of a real infection, the number of DCs bearing cognate ligand may be smaller than that in
in vivo imaging experiments (e.g., -100 - 300 cognate antigen bearing DCs are in the
draining LN at the time of T cell adoptive transfer in the experiments of Henrickson, et
al,(18)), and this time-scale may become important. It may also become important if
antigen dose is un-physiologically high, in which case the T cells would receive a
sufficiently high stimulus from the first cognate DC they encounter. As a result the time it
takes to encounter the first cognate DC dictates the duration of phase one.
An important time-scale is the time required for a productive T cell-DC encounter to
occur (i). Using a mean-field approach, we derived how this time-scale is determined by
various measures of antigen dose and type. Specifically, we identified the non-
dimensional ratio of r, and the half-life of the pMH C complex as the composite variable,
which controls the behavior of the system. Our simulation results for a wide range of
values of diverse quantities that reflect antigen dose and quality all collapse onto one
master curve when plotted against this ratio. For systems where antigen loss due to
peptide dissociation is not important, diverse results scale with C alone as it is the only
relevant time-scale.
These results show that differences in T cell migratory patterns observed upon
manipulating different variables (antigen dose, density of DCs bearing cognate ligands,
peptide stability, TCR-pMHC binding, etc.) result from how this particular change,
combined with all other prevailing conditions, affects the ratio -c/. Changing each of
these variables changes the balance between two relevant time-scales, thereby
influencing the way in which migrating T cells interact with and respond to DCs. We hope
that these implications of the conceptual framework revealed by our study will help guide
future experimentation.
Our computer simulations and experiments reported by Henrickson et al. (18) both
highlight the existence of a sharp threshold in the antigen dose on DCs, beyond which the
T cell's ability to transition to phase two drastically improves. The value of this threshold
concentration is higher for less stable pMHC ligands and weaker TCR-pMHC binding
characteristics (also observed in vitro (15)). The existence of a threshold is predicated by
the fact that dose-response curves characterizing T cell signaling exhibit a threshold (36,
41).
The time-scale associated with T cell-DC encounters is much shorter than the times at
which a transition from phase one to phase two type behavior is observed in the
experimental study by Henrickson et al.(18). This observation, combined with the fact
that there is a higher amount of pMHC ligands on cognate DCs at shorter times, led us to
suggest that T cells may be able to integrate signals from multiple serial encounters with
DCs. This aspect of our study differs from previous studies such as a recent study by
Preston et al. (48), in which the detection of antigen and activation of T cells are viewed as
a transport-limited process, i.e., the T cells commit to activation upon their first encounter
with cognate DCs. Signal integration could result from various aspects of the T cell
signaling network that may confer memory. Our calculations show that such memory
effects would enable a transition from phase one to phase two type behavior when it
otherwise may not have occurred because of too low an antigen dose on DCs. We believe
that in vivo, productive T cell - cognate DC interactions are stochastic events. The ability
to integrate signals from sequential T cell-DC encounters enhances the sensitivity with
which T cells can detect antigen. Furthermore, it may also narrow the distribution of
stochastic times at which individual T cells stop, thereby making the transition to phase
two type behavior appear to be more sharply defined.
It has been suggested that DCs may alter the presentation of pMHC ligands upon serial
encounters with T cells, which provides the source of such "memory" (8). In our current
model, this would simply result in a different type of variation of the propensity of a
productive T cell-DC encounter (k) with time. Thus, it will result in a different value for
the ratio of the two important time-scales we have identified. Nevertheless, as noted
earlier, the results will still depend only on this ratio, and simulations carried out with
DCs as the source of memory will also collapse onto the consolidated master curve shown
in Figure 4. To resolve whether the origin of "memory" lies in the T cell signaling network
and/or pMHC presentation on DCs requires the integration of molecular signaling models
with migration simulations and concomitant experiments. It is expected that the details
of the temporal migratory patterns should be different in the two cases since the
dynamical behavior of the T cell signaling network and enhanced pMHC presentation on
DCs (e.g., by clustering ligands) should be very different. Experiments aimed towards
resolving this are reported by Henrickson et al. (18).
The close connection between T cell signaling and migration revealed by our studies
highlights the need for experimental and computational studies that connect molecular
scale signaling processes to migratory patterns in detail. Multi-scale computational
models that seamlessly integrate molecular signaling events with T cell motion are
required. Furthermore, the development of efficient computer simulation methods that
do not employ a lattice representation of space and can simultaneously incorporate the
complexity of signaling are required, if all non-cognate T cells and DCs are to be included
in order to generate models that are quantitatively accurate. Similarly, experimental
technologies that can combine the tracking of T cell motion with the imaging of signaling
molecules (as is currently possible in vitro) must be developed. Synergy between such
experiments and computational studies will help elucidate how T cells are activated in
lymphoid tissues.
2.A Appendix for Chapter 2
2.A.1 Scaling the measured T cell motility coefficient to Lattice units.
Previous imaging work has suggested that the motility coefficient of T cells during phase
one is on the order of 10-20 gm2/min (9-11). Since one lattice spacing and one
elementary step correspond to 10gm and 1 minute, respectively, the motility coefficient
for the simulated migration needs to be approximately 0.1-0.2LS 2/MCS (LS = lattice
spacing, MCS = elementary MC step) to match the experimentally measured value of
10-20gm2/min. As T cells scan both cognate and non-cognate DCs for antigen, a larger
number of DCs will result in a lower motility coefficient. Thus, one can adjust the number
of noncognate DCs to obtain the experimentally measured motility coefficient. Many
simulations were performed with only non-cognate DCs present in the lattice to
determine the appropriate number of non-cognate DCs. It was found that a loading of
3,000 non-cognate DCs results in a motility coefficient of approximately O.1LS 2 / MCS, i.e.
11 gm2/min. The relevant simulation result is shown in Figure 2.A.1 in which the mean
square displacement <R2> averaged over 500 trajectories is plotted against time. The
linear dependence of <R2> on time attests to the diffusive nature of the simulated T cell
motion. Furthermore, in the case of diffusive migration in 3D, the slope of <R2> vs. time
equals 6D, where D is the motility coefficient (56). Simulation with 3,000 non-cognate
APCs results in a slope of 6D = 0.681LS 2/MCS, which corresponds to the aforementioned
motility coefficient of 0.11LS 2/MCS.
Since in most simulations performed, the number of cognate DCs is at least one order
of magnitude smaller than 3,000, the motility coefficient does not change significantly
during simulations where cognate DCs are present. Therefore, 3,000 non-cognate DCs
were used in all simulations.
2.A.2 Estimating the appropriate number of cognate DCs for the simulations.
The number of cognate DCs in the lymph node is estimated to be on the order of 300 per
lymph node by Henrickson et al. using their experimental protocol (1). The total volume
of an inflamed lymph node typically imaged by Henrickson et al. is approximately 1 mm 3 .
As frequently observed in imaging experiments, DCs are concentrated near the high
endothelial venules (HEV) via which T cells enter the lymph node. Therefore, the
pertinent number is most likely the number of cognate DCs in the volume surrounding
HEVs. Assuming that this volume is about 5-10% of the entire lymph node, and that the
300 cognate DCs are all distributed therein, the density of cognate DCs is approximately
3000-6000 DC per 1 mm 3. The volume of the lattice used in the simulations is 0.027
mm 3 . Therefore, the number of cognate DCs in the lattice should be on the order of 100
DCs. We have varied the number of cognate DCs between 100 and 1000 in our computer
simulations.
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Figure 2.A 1: Mean square displacement vs. time in units of lattice spacing and elementary MC steps,
respectively, with 3,000 non-cognate DCs on the lattice. The slope is approximately 0.68LS 2/MCS.
2.A.3 Justifications for treating DCs as stationary
dr
Diffusive motion can be described using the Langevin equation as -- = f(t) where r is adt
vector that describes the position of the particle, which is subject to a random forcef(t).
The random force is characterized by (f(t)) = 0 and (f(t)f(0)) = 6Dt, where D is the
diffusivity or motility coefficient (56). Consider a pair of such random walkers (e.g. a
motile T cell and a motile DC) whose motions are uncorrelated on time scales longer than
some short time scale present in the problem (such as the time over which a T cell and a
DC are in contact). On time scales longer than such short times, the motions of these
dr dr2particles satisfy the Langevin equation, namely -' = f1 (t) and - = f 2(t). Since theirdt dt
motions are uncorrelated, (f(t)f2 (t')) = 0Vt,t'. An encounter occurs when ri = r2.
As the Langevin equation is linear, the separation between the two random walkers
can be written as d(r, - r2 ) = f 1(t) - f 2(t). Therefore, the original two-body problem candt
be re-written as a problem with one random walker and one stationary object. Define
r'= r, - r2 and f '(t) = f1 (t)- f 2(t), then an encounter occurs when r'= 0. The diffusivity
D in this case is
(f '(t)f '(0)) (fl (t)f (0) - f (t)f 2 (0) - 2 (t)f (0) + f2 (t)f 2 (0))
6t 6t
and since there are no cross correlations,
(f '(t)f '(0)) - (fi(t)f(0)) (f2(t)f2(0)) = Di + D2
6t 6t 6t
Consequently, keeping the DCs fixed (as in our simulations) is equivalent to allowing both
DCs and T cells to move as long as the T cell motility coefficient is taken to be the sum of
the T cell motility coefficient and that of the DC. As the DC motility coefficient is much
smaller than that of T cells, ignoring the motility coefficient of the DCs does not alter any
of our qualitative conclusions.
2.A.4 Sensitivity to variations in the number of cognate DCs.
Good estimates for the number and distribution of cognate DCs in the lymph node remain
difficult to obtain. While the experimental protocol employed by Henrickson et al..
yielded approximately 300 DCs per LN (1) a loading of DCs up to 104 DCs per LN have
been reported previously (6). Simulations were carried out with a wide range of numbers
of cognate DCs. Figure 2.A.2 shows that the qualitative behavior remains the same as that
shown in Fig. 2 of the main text, as the number of cognate DCs is varied. For reasons
described in the main text, larger numbers of cognate DCs result in a lower threshold
concentration of pMHC ligands for a transition to phase two-type behavior.
2.A.5 Sensitivity to variations in the number of cognate T cells
In the model developed for this work, T cells are not permitted to co-occupy the same
lattice site. Such mutual exclusion may potentially affect the results in qualitative ways
only if the number of T cells is very high, i.e. crowding becomes significant. This scenario,
however, is not physiologically relevant. The simulation results reported in the main text
are for 500 cognate T cells, which occupy approximately 1.9% of the total number of
available sites. At such low occupancy, T cells are very unlikely to run into each other. As
demonstrated in Figure 2.A.3 for cognate T cell numbers 50% above or below 500, there
is little discernable difference in the fraction of T cells arrested upon exit. This would be
predicted by the mean-field analysis as the initial number of cognate T cells appears only
as a scale factor. Similarly, there is very little difference in the duration of phase one.
Finally, the model does not explicitly consider the presence of non-specific T cells, whose
presence will mostly affect the motility coefficient of the specific T cells in situations
relevant to this study. Therefore, the influence of non-specific T cells can be incorporated
by adjusting the motility coefficient.
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Figure 2.A 2: Variations in the number of cognate DCs do not lead to qualitatively different conclusions.
Fraction of T cells arrested and inverse phase one duration is plotted against the initial concentration of
pMHC on DCs prior to adoptive transfer, at various numbers of cognate DCs. There is no memory and
the rate of loss of peptides is that characteristic of the C-peptide in companion study by Henrickson et
al.(1).
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Figure 2.A 3: Changing the number of cognate T cells results in little change in the fraction of T cells
arrested, and only small quantitative differences in the duration of phase one. Fraction of T cells
arrested upon exit (a) and the inverse duration of phase one; (b) are plotted against the initial
concentration of pMHC on DCs prior to adoptive transfer. The peptide has characteristics similar to the
M-peptide in Henrickson et al.(1). Results for 3 different numbers of cognate T cells are shown. There
are 100 cognate DCs. The results in (b) point to the importance of fluctuations in this problem.
2.A.6 Sensitivity to variations in the scanning time upon a T cell - DC encounter.
The scanning time, rw, has two opposing effects on how effectively a T cell receives a stop
signal upon encountering a DC, as well as the duration of phase one. Increasing rw slows
down the migration of T cells, thus the frequency of T cell - DC encounters decreases. On
the other hand, with prolonged scanning, the probability of a productive encounter
.......... . . .......................... - - - --- ---- I  .. 11 -"", z:
increases. The relative strengths of these two effects determine whether increasing Tw
leads to a higher arrest fraction and shorter phase one. The increase in encounter
frequency upon decreasing scanning time only affects the duration of phase one at high
antigen loading (Figure 2.A.4). Figure 2.A.4a shows a more subtle effect. At low pMHC
concentration, increasing r, does not change the propensity of receiving a stop signal
from a given encounter. Thus the decreased frequency of encounters leads to a small
reduction in the fraction of arrested T cells. At high pMHC concentration, a longer
scanning time increases the propensity of a given T cell - cognate DC encounter to be
productive.
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Figure 2.A 4: Fraction of T cells arrested and the duration of phase one plotted against the initial
concentration of pMHCs on DCs prior to adoptive transfer, for different values of the scanning time.
100 DCs and 500 T cells are present on the lattice. No memory is implemented for these results. Results
are shown for a value of the characteristic time for peptide dissociation that is representative of the M-
peptide in companion work by Henrickson et al.(1).
2.A.7 Relationship between pMHC concentrations and probability of a stop signal, k.
As discussed in the main text, when a T cell contacts a cognate DC, it can receive a stop
signal with a probability k. k is determined by the concentration of cognate pMHC ligands,
their TCR binding characteristics, and the types and numbers of displayed endogenous
ligands. Various experimental studies have demonstrated a sigmoidal dependence of
markers of T cell activation on the dose of cognate pMHC ligands (e.g. (36, 41)). The
threshold concentration described by such a sigmoidal function depends upon TCR-pMHC
binding characteristics. In principle, detailed signaling models can provide a mapping
between TCR-pMHC binding characteristics, ligand density, and activation probability. In
the present study, we consider a general treatment and adopt a sigmoidal function, which
is empirical and not derived from detailed molecular considerations. In addition, we also
investigate different sigmoidal functions in order to examine the sensitivity of our results
to such variations. For the results shown in the main text, the sigmoidal function is
represented by the following piecewise-continuous function:
4 x10-3p(t), p(t) 3S1.2218p(t)2 - 1.9878p(t) 3< p(t) <30k1(t) =< <pt<3 Eq. 2.A.1734.118 -1 9 .7 9 05p(t)+ p(t)2
1, p(t) > 30
where p(t) is the concentration of pMHC ligands on a DC at time t. Note that in the above
expressions, the time, t, refers to the time after the DCs have arrived in the lymph node,
i.e. 18 hours or so after pulsing with peptides and injection (Figure 2.A.5). To trace back
to the pre-injection pMHC loading on DC surfaces, [pMHC]o, one needs to account for the
loss of pMHC during the 18 hours, which can be estimated as [pMHC] = p,8 exp(18/T),
where r is the time scale of pMHC loss in units of hours, which take the values of 8.7 and
3.4 hours (corresponding to half-lives of 6 and 2.35 hours) for the M- and C-peptides in
the experimental studies of Henrickson et al. (1)and most of our simulations..
t =-18 hrs t =0 t t =24 hrs
I I I
Injection [pMHCJ0  Enter LN- p(O) = p18  p(t) Exit
Figure 2.A 5: A schematic timeline showing the sequence of events.
We have explored the dependence of our simulation results on TCR-pMHC binding
characteristics by using other forms of the sigmoidal function. While keeping the
asymptotic limits for k fixed on both ends, one can alter the sigmoidal function to change
the location of the threshold, as well as the sharpness of the "switch" portion (the sharp
increase from 0 to the upper plateau). Simulations were performed using the following
alternative representations (also shown in Figure 2.A.6
= Alternative 1 (threshold moved to the right compared to Eq.2.A.1)
8 x10-3p(t), p(t) 12
ki t)= 0.5356p(t)2 - 4.9397p(t) 12< p(t)< 31
395.5824 - 31.9878p(t)+ p(t)2 1
1, p(t) 31
= Alternative 2 (sharpness reduced compared to Eq. 2.A.2)
Eq. 2.A.2
3 x10-3p(t),
k1(t) 0.6612p(t) 2 -2.5683p(t)2222.1416 - 19.9089p(t)+ p(t)
1,9
1.0
0.5
0.0
p(t) 3
3< p(t)< 27
p(t) 27
6 Original
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pMHC concentration
Figure 2.A 6: Probability for T cells to receive a stop signal upon encountering a cognate-DC (k) plotted
against the concentration of pMHC on DCs after pulsing with the M-peptide, prior to adoptive transfer.
Alternative 1 is the original mapping with the pMHC threshold moved to the right (so a higher initial
value is needed for the same probability of stopping), while alternative 2 maintains the original
threshold location, but exhibits a sharper response. As a consequence, k increases more sharply as
initial pMHC concentration is increased.
Results presented in Figure 2.A.6 illustrate that these alternative mappings only lead to
quantitative differences. Larger shifts of the threshold (e.g., of several logs) would result
in substantial changes in the ligand concentration required for a transition to phase two
Eq. 2.A.3
.. ... .. .. .. .............. 11 .  . ... ..
type behavior. Nonetheless, the qualitative shapes of the results shown in Figs. 2-4 in the
main text will not be altered. In other words, the conclusions drawn from those results
are robust to changes in the threshold location and sharpness, or alternatively
parameters that are determined by TCR - pMHC binding characteristics.
a
1.0
0.5
0.0
9 Original
A Alternative 1
9 Alternative 2
101 102 103 104
Initial pMHC concentration
0.3,
0.2,
0.1<
0.0,
101
G Original
* Alternative 1
-B Alternative 2
102 103
Initial pMHC concentration
Figure 2.A 7: Altering the detailed relationship between the concentration of initial pMHC on DCs and
the probability to receive a stop signal does not lead to qualitative changes in the results. Fraction of T
cells arrested (a) and the inverse duration of phase one (b) are plotted against the concentration of
pMHCs on DCs after pulsing, prior to adoptive transfer. 500 T cells and 100 DCs are present in the
lattice. pMHC are lost with a characteristic time scale that represents the M-peptide used by Henrickson
et al.(1). No memory effect is incorporated in these results.
2.A.8 Sensitivity to variations in the exit time.
For all simulations discussed in the main text, the exit time has been set to 24 hours (23),
or 1440 elementary MC steps, according to the conversion rule that 1 MCS = 1 minute. If
............  
...............    
there was no peptide loss with time, the fraction of T cells making sustained contacts with
DCs would increase monotonically with the exit time. If peptide loss is included in the
simulations (corresponding to the experimental situation by Henrickson et al.), the
fraction of arrested T cells saturates to a constant value if the exit time exceeds the time
beyond which most pMHCs are lost from DC surfaces (data not shown). As the exit time is
far longer than other pertinent time scales, as shown in Figure 2.A.8, the fraction of
arrested T cells is not sensitive to three-fold changes in the value of the exit time. The
only exception is when the exit time is reduced by an order of magnitude, and it becomes
of the same order as the other time scales. Based on experimental results, such scenarios
are not physiologically relevant.
0.8
-e- Texit = 500
c 0.6 x Texit = 1300
S Texit =1600
0 .4I-
0
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0
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Figure 2.A 8: Fraction of T cells arrested as a function of the initial pMHC concentration on DCs prior to
adoptive transfer for different values of the exit time. 500 T cells and 100 cognate DCs are present.
The dissociation of pMHC molecules is characterized by a time scale representative of the M-peptide in
companion study by Henrickson et al.
2.A.9 Sensitivity to alternative simulation protocols for signaling.
The simulation results shown in the main text are for cases where T cells can receive a
stop signal at any time during the scanning period, and there is no peptide loss during this
time. This seems to be the most reasonable scenario. However, we have examined the
sensitivity of our results to two alternative schemes. In the first scenario, instead of being
able to receive a stop signal during the entire scanning period (3 steps), the T cell can only
receive a stop signal during the first waiting step, i.e. immediately after the encounter
happens. In the second case, the T cell can receive a stop signal at all times during the
scanning period, but peptide loss is allowed during this time, leading to smaller values of
k. As Figure 2.A.9 shows, the original scheme used to obtain the results in the main text
and these alternatives result in very similar fraction of arrest and the duration of phase
. . .................. .  ...  ...........
..... ........ ...... . .................. .
one. In scheme 2, where the T cells have only one chance of receiving a stop signal, the
fraction arrested is slightly lower. In scheme 3, even though k decays during the scanning
period due to peptide loss (rather than staying constant as in the original scheme), the
fraction arrested and the duration of phase one is not significantly different because,
based on experimental values (1) and ((6)), tw<<t.
More importantly, the key mechanistic principle revealed by our study, the interplay
between relevant time scales, remains unchanged by changing the simulation protocol
during the scanning time. Regardless of the scheme that we choose, all simulation results
collapse onto the consolidated master curve described in the main text, as shown by
Figure 2.A.10.
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Figure 2.A 9: Fraction of T cells arrested and the inverse duration of phase one vs. the initial pMHC
concentration on DCs prior to adoptive transfer for 3 different simulation protocols described above;
scheme 1 is the one used to obtain results in the main text, and schemes 2 and 3 are described above.
100 DCs and 500 T cells are present on the lattice. Memory effect is not incorporated for these results.
Results are shown for a peptide dissociation time scale that is representative of the M-peptide in
companion study by Henrickson et al (1).
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Figure 2.A 10: All schemes for describing events during T cell-cognate DC contacts result in collapse of
all simulation results on to a single consolidated master curve. The result for Scheme 1 is Fig.3 in the
main text. Scheme 2 and 3 (a and b) are shown here. The four categories of variations in conditions that
were simulated are the same as those in Fig. 3 of the main text.
2.A.10 Sensitivity to variations in the time scale (r) over which peptide dissociation occurs.
As illustrated by the comparisons between the M-and C-peptide presented in the main
text, the value of 'raffects the time to transition from phase one to phase two. The slower
the decay is, the higher the activation probability at a given time is. In addition, when DC
homing is taken into consideration, the effect of pMHC stability is further magnified.
When DCs pick up foreign antigens at the site of infection, it typically takes hours before
. .... .  . . 
.............  ....... . .. - . .
. ....... ... ...... . .
they home to the lymph nodes. Consequently, by the time DCs enter the lymph node,
there would be fewer cognate ligands remaining on the surface of DCs for a less stable
antigen, which further limits the probability of antigen detection. To examine these two
effects, simulations were performed with a range of different values of r (i.e. a range of
pMHC stability), while keeping a constant loading of 100 cognate DCs in the lattice and a
simulation period of 24 hours. As shown in Figure 2.A.11, increasing r (and thus
increasing the pMHC half-life) greatly enhances the fraction of arrested T cells for low and
intermediate initial pMHC loadings. When the pMHC loading becomes excessive, the loss
of pMHC no longer has any effect, as reflected by the upper asymptotic limit seen in most
curves. Such high values of cognate ligand density on a DC are unlikely to be
physiologically relevant. Higher values of -r also shift the curves further to the left,
because more stable pMHCs suffer less loss during DC homing (fixed at 18 hours for all
simulations following Henrickson et al. (1). The duration of phase one (defined as the
time required to arrest 50% of the total T cells) is approximately the same for all cases
when the concentration of cognate ligands is sufficiently high (Figure 2.A.10b). This is
because at high pMHC concentrations the activation propensity is large enough to stop T
cells upon the first encounter with a DC. Under such circumstances, the duration of phase
one is more strongly dependent on the diffusion time scale (Figure 2.A.2).
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Figure 2.A 11: Fraction of T cells arrested and inverse of the duration of phase one plotted against the
initial concentration of pMHC on DCs prior to adoptive transfer, for various pMHC decay time scales ('r
). No memory effect is incorporated for these results. 100 DCs are present on the lattice.
2.A.11 Sensitivity to variations in the characteristic time scale over which memory is
manifested (Tm).
As mentioned in the main text, incorporating memory from past T cell-DC encounters into
the model does not alter the results qualitatively. We have carried out simulations over tm
that range from 0 to 4 hours to demonstrate this (data not shown). With a more
persistent memory (a larger value of tin), the decline in the probability for T cells to
receive a stop signal can be better ameliorated. By incorporating the possible effect of
memory, the threshold pMHC concentration required to induce a transition to phase two
can be reduced. Such a reduction can be used as a measure of the enhancement due to
memory (Figure 2.A.12).
0.6
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Figure 2.A 12: The decrease in the threshold concentration of pMHC required for a transition to phase
two type behavior upon increasing tm vs. length of memory time scale. D[pMHC] is defined as
.. ........ .. ....... . .. 
. . .......
[pMHC], - [pMHC], where [pMHC]c' and [pMHC]c are the required threshold concentrations with[pMHC],
and without memory, respectively. Simulation results are shown for cases corresponding to pMHC
stabilities representative of the M- and C-peptide used in the companion work by Henrickson et al.
2.A.12 The mean-field treatment and solution
The differential equation describing the number of T cells that have not received a stop
signal ( T), has the following general form:
T DV2 T - kpT
at Eq. 2.A.4
T(t=0)=To T(t, ±oo)=0
where the value of k typically varies over time as k(t) in some complicated way, as
dictated by the exponential decay of pMHC concentration, and the sigmoidal mapping
between pMHC concentration and k as described previously. In this case, the analytical
solution is not generally available. The analytical solution for two simplified cases,
however, can be easily obtained.
= No pMHC loss over time: k(t)= k
First, the equation can be non-dimensionalized by scaling the pertinent quantities using
To,re and L, where To is the total number of cognate T cells (also the initial number of
motile T cells), -re is the diffusion time scale and L is the average distance between two
cognate DCs (~ l/p 2 /3 ). Then one obtains the following:
aT -2--
= T T -,rekopTe 0 P
T TITO 2= 2 Eq. 2.A.5
T=t/1 ,=L 2 /D
T(t=0)=1 T(T,±o)=0
1Then one can define -' = I, which is the time scale for a productive T cell - DC
kop
encounter. Transforming to Fourier variables conjugate to space, one obtains
dT 2-dT = -K2T -- e , where K is the Fourier variable. The solution of this equation is
Y(T)= exp -2+ jT .To examine only the spatially averaged solution, we set K = 0
and arrive at T(T) = exp - t or T(t) = exp-- in terms of dimensional variables.
Therefore, the fraction of T cells arrested in this context is
simplyf = exp (-t/'r,)= exp (-kopt). Notice that the integral p k(t')dt' = pkit in this
case.
- pMHC decays exponentially
In this case, the equation becomes
T = DV2T - k,, exp(-t IT)pT
at Eq. 2.A.6
T(t=0)=To T(t, ±w)=0
Similar to the treatment in the first case, one can obtain the dimensionless form:
= V2T kop exp(-ret /r)T
a T
T T/TO V2 =V 2 /L2  Eq. 2.A.7
=t/Te 1,e=L 2 /D
T(t=0)=1 T(t, ±oo)=0
dT 2The spatially Fourier-transformed form is = - -Tekop exp(-rT /r) , whose
solution is T= exp[-K2- zkodp(-/exp(-rdtlI))] The spatial average of the solution,
corresponding to the case with K = 0, is T = exp[-Tkop(1 - exp(-rdt/r))]which is
T = exp[-,rkjop(1 - exp(-t /r))] in dimensional variables. Since the exit time is typically
much longer than the time scale of pMHC loss, the asymptotic limit of T
is T, -> exp [-pkor].
The mean value of Tis the integral defined in the text because
p tk(t')dt'=pkt e-'"dt'=pk(1- e-'") One can observe that in the limit of t >> r, this
integral converges to pkr. Therefore, again the fraction of T cells arrested after the exit
time has elapsed converges to f,, -> exp(-r /r,).
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Chapter 3
A computational method for simulating T cell migration and signaling
in lymphoid tissues predicts possible mechanisms for signal
integration
3.1 Introduction
The detection of invading antigen (Ag) by circulating T cells and the subsequent activation
of adaptive immune defense mainly take place in secondary lymphoid tissues such as the
lymph node (LN) and spleen, where professional Ag presenting cells (APCs), chiefly
dendritic cells (DCs), present Ag fragments on their surfaces. The molecular signatures of
Ag are peptide-major histocompatibility complexes (pMHC), where the peptides are
derived from foreign proteins. While the mechanisms via which Ag is recognized in vivo
by T cells remain to be fully uncovered, much new data has been obtained in recent years
thanks to the advent of sophisticated in vivo multiphoton and two photon microscopy
techniques (1-29). In vivo imaging of T cell triggering in LN showed that both CD4+ and
CD8+ T cells exhibit motility changes over time. For example, Mempel et al. showed that,
upon entering the LN, naive CD8+ T cells move rapidly and change directions randomly.
Their contacts with DCs, regardless of whether cognate Ag is presented, only last for a few
minutes. The time period characterized by such motility features has been termed "phase
one" (1, 2). If cognate Ag is present, however, Ag-specific T cells may terminate phase
one-type behavior and engage in stable contacts with cognate-DCs, thus entering a "phase
two" type of motility behavior. More specifically, phase two is defined to be when a large
fraction of the cognate T cells (e.g. 50%) have switched their motility characteristics (1,
2). Similar trends have been observed for CD4+ T cells (3-6).
As many such experiments were performed using different types of Ag at vastly
different doses, contradictory motility behaviors were reported, and questions arose
regarding whether phase one-type behavior was necessary for T cell activation (7). Along
with experimental collaborators, we have previously demonstrated, via experimental,
computational and theoretical analyses, that whether and when T cells transition from
phase one to phase two-type behavior is determined by the quantity and quality of
cognate Ag in the LN (2, 8). The interdependence between T cell motility features and its
activation via TCR-pMHC interactions has also been shown for CD4+ T cells recently (9).
Nevertheless, while establishing this conclusion, a new puzzle emerged. One metric
for Ag "quality" is the stability of the Ag-derived pMHCs. Henrickson et al. (10) showed
that Ag peptides dissociate from the MHC groove over time in an apparently exponential
manner. In other words, T cells are exposed to a higher dose of pMHC earlier during phase
one, before significant pMHC dissociation has occurred. If the probability for activation is
determined by the dose and strength of pMHC a T cell sees on one single DC, then the T
cells are more likely to become activated earlier on. However, Henrickson et al. also
observed that given a low initial loading of a fast-dissociating pMHC on DCs, the T cells
spent a longer time (an additional 1-2 hours) in phase one. This result presents a
paradox; namely, why does this transition not occur at earlier times when the Ag dose is
higher prior to significant pMHC dissociation? One possible answer is that T cells are
hunting for rare DCs that present unusually large doses of pMHC. Data presented by
Henrickson et al (10) argues against this possibility, as T cells appeared to distribute
uniformly in space, similar to situations where Ag quantity and/or quality were high.
Why, then, does T cell activation require a larger number of transient contacts with
cognate DCs at a relatively low dose of stimulation?
We hypothesized that since the initial pMHC dose per DC was too low to elicit a stop
signal with high probability, the T cells that eventually stopped may have achieved a stop
signal by integrating signals from multiple interrupted sequential interactions with APCs
bearing cognate Ag. Such a possibility has been suggested by several other experimental
studies (35, 37-40). Moreover, it is likely that the full activation of T cell signaling
requires the TCR membrane proximal signal to sustain beyond some critical duration
(11), and integration of sequential signals may help achieve this. Nonetheless, the
molecular mechanism that might enable integration of membrane-proximal TCR signal
(i.e. a short-term "memory" of previous encounters with DC-presented Ag) is not known.
Das et al. recently reported an intrinsic hysteresis in the TCR membrane-proximal
signaling network resulting from a positive feedback loop in the conversion of RasGDP to
RasGTP mediated by two different guanine nucleotide exchange factors (GEFs): RasGRP
and SOS (12). Specifically, Ras activation via RasGRP happens in a graduated manner
with respect to stimulus strength (analog), whereas the SOS-mediated pathway exhibits
digital signaling upon priming with RasGRP-mediated RasGTP production. After RasGDP
molecules are phosphorylated into RasGTP, they can bind to an allosteric pocket in SOS,
which drastically increases SOS' catalytic activity for producing RasGTP (13). Since the
dissociation of RasGTP from the allosteric pockets occurs over a finite period of time, after
the removal of stimulus from a strongly stimulated T cell, many SOS molecules still hold
RasGTP in their allosteric pockets and remain highly active for some time. Computational
and experimental analyses by Das and coworkers have demonstrated that, within a
certain time window, a stimulus ordinarily insufficient to elicit strong RasGTP response
may quickly trigger a fast rise in RasGTP, if the cells have been recently stimulated. This
will not occur if long enough time has elapsed such that the dissociation of RasGTP from
the SOS allosteric pockets has proceeded beyond a critical level. This threshold value of
RasGTP that allows rapid Ras activation by a weak re-stimulation is called the separatrix
(Figure 3.3.1). Das et al. showed that such "short term memory" (or hysteresis) requires
SOS, as a SOS-/- mutation abrogates hysteresis.
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Figure 3.3.1: A schematic showing the hysterisis in RasGTP production due to a positive
feedback in the TCR membrane proximal signaling network. The middle branch (dashed line)
represents the unstable steady states, while the top and bottom branches represent the stable
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steady states. A first strong stimulus Si stimulated high RasGTP production, then the stimulus
is removed. As long as RasGTP has not decayed below the unstable steady states
corresponding to the second weak stimulus (S2), e.g. point A, RasGTP level rapidly returns to
the upper branch. If RasGTP decays below the separatrix, e.g. point B, then RasGTP will
continue to decline, and the T cell will not respond to the second weak stimulus.
This result led us to postulate a mechanism for signal integration during T cell
migration in vivo. Suppose via a brief contact with a cognate DC, a T cell experiences a
sharp rise in RasGTP. The T cell disengages and migrates until it encounters another DC,
which likely presents a weak stimulus since during the disease outset the dose of Ag is
relatively low. As shown in several microscopy studies, the interval between two
consecutive encounters with DCs is very short (14, 15). Thus RasGTP levels in the T cell
may remain above the separatrix corresponding to the weak stimulus presented by the
DC encountered next. Due to the phenomenon described above, the T cell can quickly
recover a high level of RasGTP. By constructing and analyzing an in silico model, we show
that signal integration enabled by this mechanism is indeed feasible for T cells in LN and
leads to significant enhancement in T cell sensitivity for invading Ag. Note that we make
no attempt to establish this as the only mechanism for signal integration, as other
mechanisms likely exist to achieve similar functionality, and collectively enhance
detection sensitivity of T cells in vivo.
For example, an alternative mechanism for signal integration has been suggested;
namely that DCs may alter the presentation of pMHC ligands upon serial encounters with
T cells (16). One possible molecular basis for such "modification" might be that after a
transient T cell-DC encounter, the pMHC complexes become locally concentrated for a
finite period of time. If a cognate T cell arrives and interacts with the locally concentrated
pMHCs, the likelihood for a productive contact may increase. To explore this possibility
and the differences between these two mechanisms that can potentially be tested
experimentally, we adapted our model to carry out a computational study. The results
showed that this DC-based mechanism requires the enhanced pMHC concentration to
persist for a long time on a large number of cognate DCs. This seems unlikely under
physiological conditions.
To explore the mechanistic questions we raised, we also tackled a daunting
computational challenge that has not been addressed. Our studies require the
development of a simulation method that combines T cell migration with molecular
signaling, whenever a T cell-DC contact happens. The difficulty here is how to efficiently
simulate the migration of individual cells on the time scale of minutes and hours, and
length scale of microns, simultaneously with intracellular signaling events that operate on
much smaller scale. We were able to enhance our previous lattice-based migration model
to allow for off-lattice migration of the cells, while also performing fast molecular
signaling simulations using a method called Stochastic Simulator Compiler (SSC)
developed by Lis et al (17). Besides the unique advantage of combining dynamics of
disparate time and length scales while maintaining computational feasibility, this
computational platform is readily adaptable to study various other biological systems that
require simulations of cell migration subject to signaling events due to cell-cell
interactions.
3.2 Methods
Several published in silico studies have examined the migration and activation of naive T
cells in LN in the past few years(8, 18-20). The rich motility data generated by
microscopy experiments have also been subjected to sophisticated statistical analyses
(21). As the LN is densely packed with large numbers of different cells, one of the
challenges for in silico studies is how to capture the relevant biology while maintaining
computational tractability. Beltman et al. constructed a computational framework based
on the Cellular Potts Model (CPM), which was able to recapitulate many experimentally
measured T cell motility data. They demonstrated that the motility changes exhibited by
T cells, including velocity variations and stoppage, are not dictated by some internal
program in T cells, but instead are dependent on the LN environment T cells are exposed
to (18, 19). In a subsequent study, Beltman et al. also developed a method to estimate the
true distribution of T cell - DC contact time given the experimental measurements, which
are typically not comprehensive due to the very limited length of the imaging period (21).
This methodology and the knowledge of true contact time distribution may become very
useful as signal duration has been identified to have a major impact on T cell activation.
Bogle et al. developed an agent-based simulation framework, in which the space is
discretized into a 3D lattice and packed with over 1 million cells. The high packing
density in LN is faithfully mimicked while the computation remains efficient (20).
Rather than stressing quantitative recapitulation of known experimental facts
regarding T cell motility, we aimed at obtaining qualitative mechanistic insight that may
assist in the design and interpretation of analogous experimental studies. To determine
whether phase one occurs and its duration, we previously developed a lattice-based
representation of the space corresponding to the LN with periodic boundary conditions
(i.e. the edges of the box such as the left and right or top and bottom are pasted together)
in which T cells perform isotropic hopping between grid points. We also devised a simple
and ad hoc, yet mechanistically motivated, scheme to allow T cell activation in a dose-
responsive manner as they encounter DCs displaying Ag of different doses and types.
This model allowed us to derive some mechanistic insights (2, 8).
We first extended this simulation method to use a continuous representation of the LN
and avoided a lattice representation, as the former better reflects physical reality.
Periodic boundary conditions were retained to permit the simulation of large spatial
extent.
As shown in our earlier work, the explicit inclusion of non-cognate T cells does not
alter the results qualitatively but drives up the computational cost drastically (8). Thus
only Ag-specific T cells are explicitly considered here. T cells and DCs are randomly
placed into the simulation box initially as spheres with different radii. The DCs remain
stationary throughout the simulation while T cells perform random walk-like motion. As
shown by intravital microscopy, T cells typically move in a directed fashion over distances
of the order of 10gm over 1 min before changing direction randomly. To simulate such
motion in free space, a random step size is drawn from a Gaussian distribution centered
upon 10gm with a standard deviation of -2.5gm (16). A sphere with this step size as
radius and centered at the T cell can then be specified. A uniform random number is
drawn to select a point on the surface of this sphere for the T cell's new center
coordinates. Microscopy experiments have also shown that T cells can squeeze past each
other when they come into close contact, thus we define a minimal length of separation
between the centers of two T cells, which is set to be 2gm. If a proposed move leads to a
center-to-center distance smaller than this threshold value, the move is rejected. DCs, on
the other hand, are characterized by multiple long dendrites that sweep the surrounding
space and a highly non-spherical cell shape. However, if we consider the time average of
an "effective scanning volume" around a DC swept out by these dendrites, a sphere with a
radius approximately equal to the average dendrite length is an appropriate
representation. This radius is set to be uniformly 15gm. Care is taken so that in the initial
placement the DCs' "scanning volumes" do not overlap. Similar to the case of two T cells,
the minimal separation of 2 DCs is set to be 7gm, and the minimal T cell - DC separation is
5gm. In subsequent steps, any proposed move for a T cell is rejected if the relevant
separation constraints are violated. On the other hand, if the center of the T cell falls
inside a DC's "scanning volume" without violating the exclusion constraint, then the T cell
is considered to be "scanning" the DC. Very rarely would a T cell be inside the "scanning
volume" of more than one DC. Should this happen, the interaction with only one DC
(randomly chosen) is considered. The simulation period of 1440 elementary steps
corresponds to a 24-hour residence period of T cells in the LN.
Before implementing explicitly a population of DCs, let's consider the main task at
hand; namely, how to establish, with maximal computational efficiency, whether
hysteresis in the T cell signaling network can enable signal integration. The hallmark
event of such signal integration takes place when a recently stimulated T cell quickly
upregulates RasGTP as it encounters a subsequent weak stimulus. In other words, we
look for a "chain" of T cell - DC contacts with high RasGTP output, among which the first
contact most likely happens on a DC bearing strong stimulus, while the subsequent ones
occur on DCs presenting weak stimuli. Also, removal of SOS should prevent such events.
Thus, there need to be at least two types of DCs: the strongly stimulating ones which can
elicit a transient RasGTP rise in a T cell with basal RasGTP, and another group of DCs
bearing significantly weaker stimulus (i.e. fewer and / or lower-affinity pMHCs), which
may only trigger a high level of RasGTP if the T cell encountering it has a RasGTP level
above a threshold (i.e. the separatrix, see Figure 3.3.1). We will refer to the two types of
DCs as S-DCs (strong) and W-DCs (weak), respectively. Note that the strength of stimulus
on a particular DC is dictated by 2 factors: the binding characteristics (Kd) between TCR
and pMHC, and the concentration of pMHCs. In this work the "strong" and "weak" DCs are
differentiated based on the off-rate of their pMHCs with respect to TCR. Specifically, the
two types of DCs bear pMHCs of the same kon for the TCR, but with kff values differing
104-fold. Note, however, that generalizing this to concentration differences is
straightforward. Moreover, effects due to concentration differences and kff differences
can be related (8).
During phase one T cells typically interact with each DC for just a few minutes. Thus,
when a T cell comes into contact with a DC, it "scans" the DC for 3min for Ag, and the
relevant stochastic molecular signaling network is simulated using a fast implementation
of the Gillespie algorithm recently developed by Lis et al (17). This new method also
allows rule-based specification of signaling in spatially inhomogeneous environments.
This simulation method adapted to our problem takes as input the number and binding
affinity of pMHC molecules on this particular DC being scanned, as well as the number of
any residual RasGTP that may have remained from a previous productive encounter with
a DC. The output is the number of RasGTPs after the "scanning time". If a T cell has not
previously contacted any DC, or if previously activated RasGTPs have been
dephosphorylated almost entirely, then a basal number of RasGTP is used. Other details
of the signaling network can be found in Das et al (12). If the RasGTP output exceeds a
high threshold, a productive encounter is recorded. To implement the duration
requirement for a "sustained high RasGTP", the criterion for stopping a T cell for full
activation is set to be n consecutive productive encounters with DCs within a time
window AT. If a T cells has accrued n productive encounters within AT, it is considered to
have met the stopping requirements and will transition into phase two-type behavior and
no longer migrates. Otherwise, the T cell disengages from the DC and continues to
migrate until the next encounter. In between two consecutive encounters with DCs, the
RasGTP that may have formed in the first encounter decays in an exponential manner
with a characteristic time scale of 10 min until it reaches the basal level. The remaining
RasGTP at the time of the next encounter serves as an input to the signaling network
simulation. While the lack of experimental measurements prevents us from specifying
the values of n and AT, we have varied these numbers and observed no qualitative
changes in our conclusions.
The results shown here are produced by simulating 500 T cells, 3000-7000 DCs with
various S-DC versus W-DC ratios. The size of the simulation box is
300 imx300gmx300tm, thus the maximum cell-occupied volume is under 50% of the
total simulation box. Each set of conditions is simulated 60 times to obtain the statistics
shown in the Results section.
3.3 Results
Hysteresis due to positive feedback regulation allows weak stimuli to activate high level of
RasGTP production in T cells following a single productive encounter with a cognate DC..
As discussed previously, the hallmark event of the signal integration scheme under
investigation is the fast upregulation of RasGTP in T cells upon encountering a DC
presenting weak stimulus. We denote this type of event as WH, i.e. an interaction with a
W-DC that yields a high RasGTP level after "scanning". The presence or absence of such
events would provide a measure for whether signal integration happens and its relative
importance. On the other hand, the nature of the separatrix predicates that unless a T cell
has recently been stimulated strongly and still holds enough residual RasGTP (i.e. above
separatrix), the chances for a fast rise in RasGTP upon encountering a W-DC is negligible.
Our simulation results confirmed this expectation.
In a series of simulations, we maintained a fixed number of weakly stimulating pMHCs
on the W-DCs, while the number of strongly-stimulating pMHCs on the S- DCs is varied
from low to high. The number of weakly binding pMHCs per W-DC is chosen such that the
RasGTP outcome bifurcates depending on whether the T cell arrives at the W-DC with
RasGTP level above the separatrix or not. The frequencies of different types of events
were counted (see Table I for complete listing). Experimentally, the RasGTP hysteresis
disappears in the SOS-/- mutants (12). Therefore we also performed simulations with an
identical signaling network with zero SOS molecules to mimic the SOS-/- mutants. In the
simplest case, we considered the activation criteria that a T cell needs to acquire two
consecutive high RasGTP-inducing contacts within a window of 25 min, i.e. n = 2, AT = 25.
If n > 2, the results are qualitatively similar.
Figure 3.3.2 shows the fraction of WH-type events among all T cell - DC encounters as
the pMHC loadings on the S-DCs are varied. The ratios between W- and S-DCs (Nw/Ns),
and the total population of DCs (Nito) were varied to obtain the different curves shown in
Figure 3.3.2. In T cells capable of feedback regulation (containing SOS), above some
threshold pMHC loading, the fraction of WH-type events becomes positive. As the pMHC
loading increases further, this fraction decreases sharply by a small amount and reaches a
plateau value. On the other hand, in SOS-/- T cells, the number of WH-type events is zero
regardless of pMHC loading on S-DCs. Loss of Ras-SOS-dependent hysteresis abrogates
the T cells' ability to integrate signals, as expected.
There are some interesting features in the shape of the graphs for WH. For example, the
common threshold pMHC loading defining the onset of conditions that enable signal
integration for all variations in DC population and composition, as well as the plateau
value Of WH. How may one rationalize the shape of these curves? Let's first consider how
may a WH-type event occur, and then analyze how the pMHC loading on S-DCs affects
these processes.
First of all, a WH-type event requires a T cell to have been strongly stimulated in the
recent past. This requires a recent encounter with an S-DC bearing a sufficient number of
high-affinity pMHC, because W-DCs are not able to stimulate naive T cells with basal
RasGTP levels. The probability of this happening is either close to 1 or nearly 0,
depending on whether the pMHC loading on S-DC is above or below a threshold, which is
entirely dictated by TCR-pMHC binding characteristics. Therefore, so long as the TCR-
pMHC binding characteristics stay constant, the location of this threshold remains
unchanged, as seen in Figure 3.3.2. Below this threshold, the S-DCs are not sufficiently
stimulatory and WH-event cannot occur, hence its absence for stimulus levels below the
threshold. At the threshold pMHC concentration, this fraction reaches its peak, i.e.
signaling integration's enhancing effect is the most prominent. Above this pMHC loading
on S-DCs, due to increasing pMHC loading on S-DCs, their ability to activate T cells quickly
reaches 100%. Thus, more S-DCs lead to high RasGTP levels, making the relative
contribution of W-DCs to the total number of productive encounters smaller. Thus the
fraction of WH-type events decreases slightly.
Figure 3.3.2 shows that when the number of high affinity-pMHCs on S-DC is high (i.e.
high stimulus levels), WH reaches different plateau heights depending on the composition
of the DC population. The plateau heights can be calculated using a set of probabilistic
arguments. After a productive encounter with an S-DC, a T cell departs with a high level
of RasGTP and soon arrives at a second DC. Several outcomes are possible depending on
whether this T cell subsequently reaches an S- or W-DC, and whether its active RasGTP
level has decayed to a level below the separatrix value, denoted as R* in Table I. These
scenarios can be explained as the interplay of competing time-scales. Thus, before we
calculate the probability for each possible scenario, we need to first identify some
important time scales.
The total number of DCs loaded into the simulation box determines the average time it
takes for a T cell to migrate from one DC to the next. This average time between 2
consecutive T cell - DC encounters is denoted as rT. It scales with the motility coefficient
1
of T cells, D, and the density of all DCs, p, as P ~/3 . At the parameters used in our
simulation, this time ranges from 4 to 6min, depending on the number of DCs (i.e. p) in
the simulation box. The statistics gathered from simulations are consistent with this
estimate. Another important time-scale is the characteristic time for RasGTP decay,
which we will be denoted as rTd. As Das et al. have shown, the ability to integrate signal
conferred by the Ras-SOS feedback loop lasts for at least 10 min.
Since the arrival at a DC and the decay of RasGTP during migration are two
independent processes, their probabilities are independent. In our simulations, the T
cells perform isotropic random walks while the DCs are randomly placed according to a
uniform distribution. Thus, the probability that the next encounter happens on a W- DC
N
as opposed to an S-DC, denoted asf, is simply the fraction of W-type DCs, W , where
N,+ Ns
Nw and Ns denote the number of W- and S-DCs, respectively. On the other hand, since the
migration of T cells and the dephosphorylation of RasGTP to RasGDP are both first order
T
events, the probability that the former event occurs before the latter is simply T T
e +Id
which we denote as x. Using x andf, we can calculate the probability of each possible type
of event (Table I). The frequency of WH events is the productfx. Given the DC population
makeup,f can be calculated. The average time between two consecutive T cell - DC
encounters can be estimated from either the DC densities or from encounter time
statistics gathered from the simulations (4-6min, as mentioned above). Table II lists the
percent discrepancy between the predicted probability of occurrence of WH-type events
(related to the plateau value in Figure 3.3.2), using this argument and the simulation
results. There is overall a good agreement between them.
Code DC type Residual RasGTP RasGTP output Probability
W/L/L W <R* Low f(1-x)
W/L/H W <R* High 0
W/H/L W >R* Low 0
W/H/H W >R* High fx
S/L/L S <R* Low 0
S/L/H S <R* High (1-f) (1-x)
S/H/L S >R* Low 0
S/H/H S >_R_ * High (1-f)x
Table I: In the n = 2 case, all possible scenarios for T cell - DC encounters subsequent to a
productive T cell - S-DC encounter are listed here, followed by their probability. W and S
stand for the "Weak" and "Strong" DCs. The first letter denotes either weak (W) or strong (S)
pMHC stimulus presented by the DC in contact. The second letter stands for high (H) or low
(L) residual RasGTP upon T cell arrival. More specifically, "high" and "low" are distinguished
by whether the RasGTP level remains above the separatrix or has decayed below it. The third
letter stands for high (H) or low (L) RasGTP output from the current encounter after
"scanning". Here, "high" and "low" refer to the upper and lower steady states (see Figure 3.3.1
in main text for more details).
DC population makeup N/N % error
1500/1500 4%
Table II: The frequency of WH events in T cell - DC encounter subsequent to a first productive
encounter using the probabilistic arguments described in the text, and directly estimated from
simulation results. Total DC number ranged from 3000 to 7000, and percentage of "W"-DC
from 30% to 90%. The % deviation of the probabilistic calculation from simulation results are
denoted as % error.
To summarize, hysteresis resulting from the Ras-SOS feedback regulation does indeed
confer T cells the ability to integrate signals from sequential encounters with DCs. The
degree to which such signal integration enhances the activation of T cells is dependent on
the TCR-pMHC binding characteristics and the composition of the DC population. At the
threshold level of pMHC stimulus, the enhancement in T cell activation due to signal
integration is the highest. Under physiological conditions, the pMHC stimulation during
the onset of a disease may be near such threshold levels. Therefore, signal integration
may play an important role in improving the detection sensitivity of T cells.
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Figure 3.3.2: Fraction of WH-type events among all productive encounters subsequent to a "chain
initiating" S/L/H event (see Table I). Simulations were carried out with 3 different DC population
compositions with total DCs numbering 5000 or 7000, and with either 90% or 30% of all DCs bearing
high kff pMHCs ("W"-DC). SOS-/- T cells are simulated with 4500 "W"-DCs and 1500 S-DCs.
Signal integration is unnecessary when there are abundant and potent pMHC stimuli.
In Figure 3.3, the fraction of T cells arrested given different numbers of "W" and S- DCs
is plotted against the number of pMHCs on S-DC on a log scale. To see how the
composition of the DC population affects the activation of T cells, the total number of DCs
and the ratio between "W"- and S-DCs, Nw/Ns are varied.
First, a common feature among them is that when the pMHC loading on S-DCs becomes
very large, SOS-/- T cells can compensate for their inability to integrate signals to varying
degrees and achieve variable sizes of activated T cell population. The degree of such
improvement is dependent on the DC population. If the total number of DCs is increased
from 5000 to 7000 while keeping Nw/Ns constant at 9:1 (i.e. x = 0.9), then the plateau
rises asfreduces. On the other hand, if Nw/Ns is reduced from 9 to 1, due to the greatly
increased presence of S-DCs, x decreases from 0.9 to 0.5, the fraction of T cell arrested
also increases. In fact, with a high enough loading of S-DC, there is no longer any
difference between WT and SOS-/- T cells in their abilities to activate T cells. Thus, the
contribution to T cell arrest from signal integration decreases as the relative abundance
and potency of S-DCs increases. In experiments where large numbers of potently loaded
DCs are used to present Ag to the T cells, f is nearly zero, since Nw<<Ns. Consequently,
signal integration does not play a significant role. Our results (Figure 3.3) may explain
why in some experiments, phase one-type behaviors were not observed (7). Note that
this is not expected to represent physiological conditions during the onset of a real
infection. In those cases, cognate and potent DCs are relatively scarce.
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Figure 3.3: Fraction of T cells arrested after the total simulation time has elapsed in WT T cells
capable of Ras-SOS digital signalings and SOS-/- T cells. Two values of the total number of
DCs and 2 values for the ratio of N,/Ns are comapred. The 3 different sets of DC compositions
are i) Ntt = 7000, Nw/Ns= 3500/3500=1; ii) Nt = 7000, Nw/Ns=6300/700=9; iii) Nt, = 5000,
Nw/Ns= 4500/500=9.
DC-mediated signal integration exhibits distinctly different dependence on DC numbers and
other system parameters.
The ability to integrate signals may not only reside on the T cells. In fact, certain
characteristics of DCs also affect the duration and quality of a cognate DC-T cell
engagement. Experimentally, it has been shown that the maturation state of DCs may
dictate whether DCs can form stable and long-lasting conjugation with T cells (16, 22).
The authors suggested that maturation allows for surface modifications that enhance
adhesion of mature DCs to T cells, and that such a stabilizing effect is Ag-independent.
While no molecular mechanism was proposed for these results, they do prompt us to
consider an alternative signal integration mechanism due to modification to DC surfaces.
Additionally, it provides an opportunity to demonstrate that the computational platform
we have constructed is indeed versatile enough to be readily adapted to study diverse
situations.
Specifically, we consider the following scenario. As a T cell leaves the surface of a
cognate DC after a brief contact, there may be a locally enhanced concentration of pMHCs,
as pMHCs may have gathered in the contact zone. Such locally enhanced pMHC
presentation may persist for some finite time. Meanwhile, if another T cell interacts with
this DC before such locally enhanced pMHC presentation fully dissolves. The likelihood of
a productive interaction may increase. Our in silico model can easily be adapted to
examine such "DC-mediated signal integration", and compare it with the previously
described T cell-mediated scheme to suggest ways to differentiate between the two
schemes.
To simulate this situation, first the "T cell signal integration" is turned off by using a
population of SOS-/- T cells. Most other parameters, procedures and activation criterion
remain the same, and all DCs present a default baseline pMHC concentration. Then as
encounters with T cells happen, the pMHC concentration on DCs undergo changes as
follows:
1) If the DC interacts with a T cell at the baseline pMHC concentration, denoted as
[pMHC]o, after the T cell disengages, its pMHC concentration is increased by some
fractionf+, i.e. [pMHC]=(1+f+)[pMHC]o to represent a "clustering" effect.
2) As time progresses in the simulation, this "enhancement" in pMHC presentation
decays exponentially with some time scale, rd" (different from the decay time
scale, -rd, in the "T cell signal integration" case).
3) If a DC encounters another T cell while its [pMHC] is elevated, we simulate the T
cell signaling network with [pMHC] at the time of encounter. And if the T cell
leaves, this DC's [pMHC] returns to the fully enhanced level, i.e. (1+f+)[pMHC]o.
This is based on the consideration that during a T cell-DC conjugation, pMHC
molecules may migrate towards the contact zone, and thus become further
concentrated.
4) Should a DC simultaneously engage several T cells, one may expect some
competition for pMHC among different contact zones. As the total number of
pMHC is conserved, these T-DC contact zones may not all experience equally
elevated pMHC concentration at the same time. To simplify the simulation, we do
not currently consider such conservation of total pMHC. This approximation
provides an upper bound for the increased activation propensity due to enhanced
pMHC presentation, as in reality, some T cell interacting with a single DC may not
benefit from enhanced pMHC presentation.
Due to the speculative nature of this scheme for signal integration, relevant
parameters also need to be postulated. However, by performing a time scale analysis
similar to what was done for the "T cell signal integration", we can examine the functional
dependence of simulation results on these parameters. Then some simulation results
using parameters informed by time scale analysis will be discussed.
The activation criterion stipulates that an encounter leading to RasGTP signal above
some threshold is productive, and that a T cell must receive 2 such successive productive
encounters to become arrested within a time window, AT. As discussed earlier, the time
between 2 consecutive contacts with DCs by a certain T cell has an exponential
distribution, with an average value denoted as ie. A superscript of "T" is used to
differentiate from an analogous quantity defined for DCs. The probability that a T cell
arrives at a DC before AT elapses is the cumulative probabilityl-exp(-AT/rT).
Switching to the DC side, what's the probability that when this encounter happens,
there remains sufficient pMHC enhancement to facilitate a productive conjugation?
Encounters with such DC likely will be productive only if the enhanced concentration has
not decayed below some threshold. Suppose this duration of "effective enhancement" is
T. Then for a T cell to benefit from such enhancement, it must arrive at the DC within Tm
time steps after the previous T cell's departure. What is the time for a second T cell to
arrive at a DC after the previous one has left? Similar to the characteristic time for a T cell
to reach a DC,?e, this is also an exponential random variable. Denote this time as C. Its
1e
value is related to the density of T cells, pr, as T ~ m Since exp(-3)= 5% (i.e. 95%
loss), within 2-3 DC, this enhancement will dissipate entirely. Thus Tm can be maximally
1-2 rDc. At the time of T cell - DC encounter, if we know whether this DC has waited
more than Tm since the last visit of a T cell, then the probability calculation is complete.
The time that its last encounter was no more than Tm ago is simplyl - e-T.r-'.
Taking advantage of the fact that the encounters between different T cells and DCs are
largely independent, the overall probability for a T cell to encounter a DC while they are
both able to potentially produce a productive contact is (1- e-^'I)(1 - e-C' )
This expression can be simplified further. First consider the case that rDC >> Tm, or
T
T <<1. Under physiological conditions, this may be true as the number of naive T cells
TDC
of a particular specificity is very small, thus pr is small. As a consequence, rDC is large.
For a DC to consecutively encounter 2 cognate T cells, the time interval will be very long.
C TThen via series expansion and retaining the first term, 1- e-.' =--. Thus this
le
probability scales as P ~ T(1-e-A'I) . Note that since l- eA'I <1, and <<1, this
,r DC 1 .DC
e e
probability is typically low. Simulation results corroborated this point, as shown by a
comparison in Figure 3.4a. If the enhancement factor,f+, is 1 (pMHCs are twice as
concentrated after encountering with a T cell), and if the time scale of decay. As r-c _
20min (comparable to AT, moderate rate of decay), there is no visible enhancement in T
cell arrest due to the presence of such DC-mediated signal integration. With a higher
enhancement factor,f = 3, the improvement is still moderate (Figure 3.4b).
Alternatively, if >>1, then P ~ (1- eAT'c). As discussed previously, AT /r is of
order 1 or larger, which implies that the probability P is close to 1. In other words, if the
enhancement of pMHC presentation on DC persists for long time (much longer than the
T
time for 2 T cells to hit the same DC, or - >>1), then such DC-mediated signal
reC
integration can lead to significantly greater likelihood for productive encounter with T
cells. Hugues et al. and Benvenuti et al. showed that the period when matured DCs are
able to engagement T cells with improved stability is on the order of 10 hours (16, 22).
Though the mechanism considered here is different, it also requires a modification to DC
surface that persists for a very long time to be effective. This is shown in Figure 3.4b.
Increasing the decay time scale, rC, by a factor of 2 from 20min to 40min, the threshold
dose of pMHC required to arrest T cells drastically is reduced by a factor of about 1.9,
consistent with the linear dependence of Tm.
Next we will use this probability expression to see how the DC loading may influence
DC-mediated and T cell-mediated signal integration in different ways. Recall that in the T
cell-mediated case scenario discussed above, the probability of a second productive
encounter due to signal integration is 1 -f+fx (see Table I for full details), or
N 11 s I . Increasing the number of DCs leads to a smaller Te. The second
Ns +Nw 1+
term is small, thus the probability is close to 1. In other words, if T cells encounter DCs
more frequently, a larger fraction of the productive encounters that took place were
results of signal integration via T cell-mediated signal integration. As seen in Figure 3.3,
with progressively higher DC density and S-DC fraction, the threshold concentration of
pMHC required for T cells to be arrested reduces. However reducing ?e does not lead to
the same improvement in DC-mediated signal integration. For example, if Ce is reduced
by a factor of 2, then the improvement in activation probability is only
(1-e-25 /3)
-1 0.016. Simulation results concur with this estimate. We increased the
number of DCs by a factor of 2.8 to reduce Te by a factor of 2, the improvement is very
small (Figure 3.4a). Finally, note that in order to isolate the effect of enhanced pMHC
presentation of DC, the Ras-SOS feedback loop was disabled in the T cells simulated.
These simulated SOS-/- T cells are less sensitive to pMHC stimulation than WT T cells,
which is partially the reason that the threshold pMHC dose to trigger T-cell-mediated
signal integration is orders of magnitude lower than the DC-mediated case (Figure 3.4b).
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Figure 3.4: The effect of DC-mediated signal integration. 500 T cells and 500 S-DCs are placed in a
simulation space 135mmxl3Smmxl35mm in size. The degree of pMHC "clustering" is
represented as the increase in [pMHC], orf.. The time scale over which such enhanced [pMHC]
persists is either 20min or 40min. Figure 3.4.a and b both contain the case without either T cell-
mediated or DC-mediated signal integration (purple circles). Results with T cell-mediated signal
integration while holding all other parameters the same are shown in b (red triangles).
3.4 Discussion
T cells are known for their remarkable sensitivity in detecting invading Ag in secondary
lymphoid tissues, even during disease onset when only a few cells among hundreds of
millions of DCs are presenting Ag, and the Ag-presenting pMHC per DC may also be
relatively low (23). In recent years, intravital microscopy techniques have provided an
.......   .
effective means to help understand the initiation of T cell activation in vivo. Among the
first discoveries is that the T cells exhibit a type of motility behavior characterized by
random walk-like motion upon entering the LN, and transient engagement with either
cognate or non-cognate DCs along the way (1, 14). In the presence of Ag, some T cells
stop on the surface of cognate DCs for stable conjugations that last for hours (1-5, 7, 14-
16, 24-27). In our previous work, we showed that whether and when the T cells
transition from phase one to phase two depends on the quality and quantity of Ag in the
environment (2, 8). Observations from experiments also suggested that the T cells may
integrate sequential sub-optimal signals derived from transient interrupted encounters
with DCs to achieve activation, in the absence of DCs bearing potently high concentrations
of pMHCs (28). Such enhancement in detection sensitivity was further corroborated by
our simulations (2, 8). However, the molecular origin of this ability to integrate signals
from multiple interrupted encounters was unclear.
A recent finding suggests that the TCR membrane proximal signaling network exhibits
hysteresis due to positive feedback regulation of Ras activation by SOS. This is a plausible
mechanism for signal integration. In order to explore whether hysteresis in the
membrane proximal signaling network can lead to signal integration, we carried out a
computational study. Carrying out this study required the development of a
computational algorithm that could simultaneously simulate T cell migration and
stochastic intracellular signaling. We have developed such a hybrid computational
method. The migration of T cells is simulated in continuous space by a Monte-Carlo
algorithm, and every time a T cell encounters an APC, a stochastic Gillespie simulation of
the signaling network is carried out on the fly (12, 13). Our method is very general, and
can be applied to a variety of different biological systems where both cell migration and
signaling occur simultaneously. Our computational framework decouples the
implementation of migration and cell contact from intracellular molecular signaling
networks. Therefore, one could implement an alternative signaling scheme without
having to alter the migration simulation.
Our results enable us to assess the feasibility of our signal integration hypothesis. The
results suggest that hysteresis due to positive feedback regulation can indeed provide a
mechanism for a "short term molecular memory" in vivo. The contribution to the total
number of productive T cell - DC encounters due to signal integration is particularly
prominent when the number of potently stimulatory DCs is low. Loss of SOS abrogates
the ability to integrate signals via this mechanism.
Conceptually, experimental verification of these results can be straightforward, should
it be possible to experimentally monitor the level of RasGTP or other related signaling
products in real time as T cells migrate. First of all, many model antigens have altered
peptide ligands (APLs) with greatly different affinities for the same TCR. Thus the S- and
W-DCs in our model can be implemented experimentally. By titrating the pMHC loading
per DC and the total loading of cognate DCs into the LN, then tracking signaling dynamics
paralleled with T cell migration, signal integration and its dependence on various
parameters can be studied. Finally, similar experiments with SOS-/- T cells can serve to
examine its role in enabling signal integration. SOS-/- T cells should lose the ability to
integrate signal unless a much higher pMHC dosage is used. The primary barrier to
carrying out such experiments is to simultaneously image migrating T cells and signaling
molecules within them. A recently developed mouse model that enables imaging of
calcium signals while carrying out intravital microscopy experiments seems promising in
this regard (8).
We also explored the possibility of DC-mediated signal integration, based on the
speculation that transient contact with T cells may alter the pMHC presentation on DCs in
ways that favor T cell activation. The computational platform we have constructed was
readily converted to address this problem. We found that in reasonable parameter
ranges, the probability of such DC-mediated signal integration is low, and its contribution
to T cell activation is minimal. The bottleneck lies in the requirement for large number of
cognate T cells, which is not likely under normal physiological conditions.
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Chapter 4
Summary and future steps
4.1 A summary of completed studies
The overarching theme of this thesis is to develop efficient computational models for
studying the triggering of T cells in vivo. More specifically, the models were designed to
capture pertinent key features of the corresponding physical reality while maintaining
computational feasibility. All modeling efforts were in close synergy with experimental
investigations. Specifically, I postulated mechanisms based on experimental
observations, especially ones that are counter-intuitive. Then the mechanisms were
implemented as computer programs and simulated to obtain numerical results. Different
analytical tools including PDEs, ODEs, and Markovian probability were also employed to
help derive mechanistic insights from simulation results. The results of these efforts
finally fed back to the experimental investigations by 1) providing explanations for
puzzling results; 2) suggesting new experiments for the testing of proposed mechanisms.
In Chapter 2, with experimental collaborators Sarah E. Henrickson and Uli von Andrian,
I investigated how the quantity and quality of Ag in the LN may affect T cells' decision to
stop migration and engage cognate DCs in stable conjugation. In the microscopy
experiments by Henrickson et al., it was observed that class-I restricted P14 T cells first
perform rapid diffusive motion and transiently engage DCs upon encountering them.
After several hours of such phase one type behaviors, should the DCs bear appropriate
type and amounts of Ag, the T cells will cease migration and engage a cognate DC for long
periods of time, after which they become activated T cells and begin to proliferate (1).
The controversy we wanted to address was whether the stopping of T cells was dictated
by a predetermined developmental program internal to the T cells and independent of the
LN milieu. We hypothesized that the decision to stop was a response to the Ag presence
in LN, rather than an internal program. The testing of this hypothesis requires a model to
track a large number of T cells individually as they migrate randomly in LN and interact
with DCs. Upon an encounter, the model also needs to stochastically determine whether
the T cell would enter phase two-type behavior based on the type and the number of
pMHC present on this particular DC. In short, the objectives posed a multi-scale challenge.
The solution was as follows. I developed a model of random walk on a cubic lattice to
simulate the migration of T cells during phase one, with relevant migration parameters
matched to those measured or estimated for the experimental analogue of Henrickson et
al. A probability for T cell stopping upon encountering a cognate DC was drawn from a
dose response curve, each time a T cell - DC encounter occurs. Drawing this propensity
from a postulated dose-responsive curve of the correct qualitative shape allowed us to
bypass simulating the T cell signaling network every time a T cell encounters a DC. A
sensitivity analysis on the dose-response curve further showed that the simulation results
do not vary qualitatively so long as the dose-response curve retains its shape (2).
Together with our experimental collaborators, we showed that whether and when a T
cell may stop the random migration and perform stable conjugation with a DC depends on
the dose and type of Ag being presented by these DCs. Our theoretical analysis further
revealed a single parameter dictating the duration of phase one. Using this parameter, the
results from varying a diverse set of parameters all fall onto one consolidated curve. With
the help of this consolidated master curve, I was able to explain a previously puzzling
experimental observation by Henrickson et al. Specifically, varying the number of cognate
DCs in LN has a linear effect on the probability of T cell stoppage, whereas increasing the
number of pMHCs initially loaded onto individual DCs improves this probability in a
super-linear fashion. Therefore they are not interchangeable (1, 2).
Another puzzling observation from this set of experiments initiated the investigation
covered in Chapter 3. As shown in Chapter 2 and corresponding publications, pMHC
dissociates over time, resulting in a progressively lower dose of Ag stimulation. At the
threshold dose of pMHC required to elicit a phase two-type behavior, T cells spent more
time in phase one before the transition into phase two. This is counter-intuitive because
prior to significant pMHC dissociation, the Ag stimulation was stronger and more
favorable for activation. T cells should have stopped migration earlier rather than later.
One possible explanation is that T cells are able to integrate sub-optimal signals derived
from several successive encounters with DCs. To test this hypothesis, a molecular
mechanism to enable "signal integration" is required.
By taking advantage of a newly discovered, bi-stable signaling module in the TCR
signaling network (3), I was able to formulate such a mechanism. In lymphocytes, the
catalytic conversion of signaling molecule RasGDP to its active GTP form by SOS exhibits
bi-stable behavior due to the positive feedback regulation in this process. Because of the
associated hysteresis, a recently stimulated cell with residual active RasGTP can quickly
return to a high RasGTP-state after a weak stimulation. This does not happen in T cells
that have not recently been stimulated (3).
I postulated that T cells require several consecutive "productive" encounters (high
RasGTP-producing) with DCs to fully stop. During the migration period between 2
consecutive encounters, the previously converted RasGTP gradually decays back into its
GDP form. If a subsequent encounter with a DC occurs before RasGTP level has decayed
beyond a critical level, a subsequent weak stimulus cannot trigger T cell (details see
Chapter 3 and (3)). The computational model described in Chapter 2 was adapted to
incorporate signaling and T cell migration simultaneously. A fast implementation of the
TCR membrane-proximal signaling network was developed separately to simulate the
reactions from TCR-pMHC engagement to RasGTP production. Then this simulation was
integrated with a simulation of T cell migration in free space. The resulted in silico model
encompasses dynamics that occur within microseconds inside a cell, as well as those
which occur over many hours, at the cell population level. The full history for each cell
could be recorded for analyses.
The results showed that the bi-stability inherent in the Ras-SOS feedback loop does
enable T cell to integrate signals. With signal integration, T cells are arrested by cognate
DCs at much lower doses of Ag stimulation than otherwise. Thus, signal integration may
be physiologically important as it enhances the detection sensitivity for Ag. These results
have motivated the design of new experiments.
Finally, besides being fast and robust, the computational framework can be easily
adapted for other possible mechanisms of signal integration, or other problems in
biological systems that require an understanding of the interplay between signaling and
cell migration. I included two such examples in Chapter 3. First, a DC-based signal
integration scheme was investigated. It has been proposed that DCs may undergo surface
modifications that render them more effective at stimulating T cells (4). In other words,
the ability for "signal integration" may instead reside on the DCs. I modified the in silico
model to test out such a possibility. I discussed the difference between the two
alternatives and possible experimental tests. The other example is the infection of liver
cells (hepatocytes) by the hepatitis C virus (HCV). Though the problems of T cell
triggering and HCV infection may appear disparate, our computational framework was
poised to address the multi-scale nature of the HCV problem.
4.2 The next step: T cell proliferation in vivo
Encouraged by the progress in studying T cell triggering, I became interested in the
dynamics on greater scales. This entails a further expansion in the time- and length-scale
one must consider. In this section I will first motivate the approach I selected for
studying T cell proliferation in vivo. Then I will briefly discuss an experimental study
based on which a well-defined question was formulated. These will prepare us for the
discussion on the initial modeling efforts in section 4.3.
4.2.1 Motivation
As complex as it is, the arrest of a naive T cell on the surface of a cognate DC only marks
the beginning of a series of complex downstream activities, which not only lead to
immediate immune defense actions targeting the ongoing infection, but also create an
"immune memory" that persists for years to come.
Following TCR-pMHC engagement, a plethora of intracellular molecular reactions
ensue within the T cell. Expression of new surface proteins and cytokines can begin
within minutes. Activated T cells soon begin to proliferate over the next few hours, up to
several days, greatly increasing the number of T cells of this particular clone. Some time
during this proliferation phase, activated T cells update their surface adhesion properties
and begin to gradually exit from secondary lymphoid organs. They travel via blood
circulation and enter peripheral tissues, where they carry out effector functions. After the
primary response, most of the activated T cells die during a contraction phase, while a
small fraction persists throughout the organism's lifetime to maintain an immune
memory. This memory response is also often referred to as the secondary or recall
response.
Many experimental studies have shown that the effectiveness in both the primary and
the recall response are dependent on the binding of TCR to pMHC. This implies that the
knowledge of TCR-pMHC binding characteristics is extremely important for the prediction
of dynamics of both primary and secondary responses. Compared to their in vivo
counterparts, in vitro studies of TCR-pMHC binding and their impact on the primary and
recall functions are much easier to conduct, and have generated a far greater wealth of
data. Thus the central question becomes how can we use these in vitro measurements to
glean some insights on the in vivo dynamics, which are far more functionally relevant?
To translate in vitro measurement into in vivo predictions is no trivial task. Despite
the great necessity for such knowledge and the tremendous efforts devoted to studying
this question, the answers remain shrouded in mystery. The first step toward mapping
the in vitro measurements to their counterparts in vivo is to identify the factors that cause
the in vivo observations or measurements to differ from those in vitro, and find out how
these factors operate in both cases.
A major drawback of in vitro setups is that they lack the plurality of interacting cells
and biochemical messengers abundant in the in vivo environment. Furthermore, the
immune system is cohesively regulated at the level of the entire organism. In vitro
studies, on the other hand, cannot reproduce such aspects. Therefore these are the areas
on which efforts should be focused.
One faces several hefty obstacles were one to investigate these areas using a modeling
approach. Earlier we have seen how the mingling of different time- and length-scales may
pose great challenge to any modeling effort. Here, consideration of the dynamics at the
organism level entails treatment of even longer time- and length-scales. Secondly, we are
still constrained by the lack of understanding at the molecular level, similar to the
previous studies but to a more severe degree. Constructing an informative model from
the limited knowledge available without adding too many hypothetical elements that
dilute the model's biological relevance is great challenge.
To cope with these difficulties, a more realistic approach is to define a very specific
question, which focuses on a small subset of the areas of in vitro-in vivo divergence
mentioned above. One can then identify the most relevant subset of dynamical events at
different levels, and reduce the number of different time-scales we need to
simultaneously consider. This choice must be motivated by the available experimental
data.
Experimentally, the main measurable quantities of the primary response include the
proliferation kinetics and the size of peak T cell population. They are relatively
straightforward to monitor both in vitro and in vivo, and have been shown to strongly
correlate with TCR-pMHC binding affinity. We also need to ponder how to incorporate
elements from the vast array of cell types and signaling molecules involved: enzymes,
cytokines, receptors, etc. The choice will again be dictated by available experimental data.
In the next section, I will describe an experimental study, in preparation for the
discussion of a hypothesis and model built upon the data and observations from this
study.
4.2.2 CD8+ T cell proliferation in vivo: some puzzling observations
In a recent study, Zehn et al. studied how TCR-pMHC binding affinity affects the primary
and secondary functions of activated T cells in vivo (5). The T cells used were OT-I CD8+
T cells bearing transgenic TCRs that bind to ovalbumin (OVA) epitope with high affinity.
Recombinant Listeria monocytogenes were engineered to express ovalbumin (OVA). To
focus on the effect of different binding affinities, altered peptide ligands (APLs) of the wild
type (WT) epitope N4 were derived by mutating one amino acid in the WT sequence. The
APLs all form pMHC complexes with H-2Kb equally well but differ significantly in their
ability to stimulate OT-I cells to produce IFN-y in vitro.
For the in vivo experiments, 3000 OT-I cells were transferred into each mouse. This
low number of adoptive transfer more closely mimics the physiological frequency of T cell
precursors. After the adoptive transfer of these OT-I cells, the mice were infected with
recombinant Listeria. The OVA epitopes are presented by a type of class-I-restricted
MHC, H-2Kb. Though endogenous T cells in these mice also respond to OVA, within 4
days, OT-I T cells have outgrown the endogenous population by at least 30-fold, which
implies that clonal competition from the endogenous T cells was insignificant. Zehn et al.
found that despite significant difference in their avidity, pMHCs of different APLs
stimulated comparable T cell division through the first 4 days. Afterward, the OT-I cells
activated by higher-affinity APLs continue to proliferate for 2-3 days, reaching their peak
expansion and began to contract. Meanwhile, OT-I cells stimulated with lower affinity-
APLs reached peak expansion earlier at a lower peak population, and began to contract
much earlier. On the other hand, their exit into the blood appeared earlier than those OT-
I cells stimulated by higher-affinity APLs.
Various phenotype markers were also assayed in these experiments. During the initial
4 days when T cells stimulated by different APLs exhibited comparable proliferation, the
T cell surface markers were also found to be comparable, with the only exceptions of
CD25 and C-C chemokine receptor 7 (CCR7). CD25 is the a-subunit of the interleukin-2
(IL-2) receptor (IL-2R), while CCR7 is involved in T cell homeostasis. Their biology will
be discussed in further details later on. In T cells activated by lower-affinity APLs, these
two markers were also lower on day 4. Aided by microscopy data, the authors pointed
out that this earlier down-regulation of CCR7 is consistent with the earlier egress of T
cells from LN.
In addition to measuring the primary response, Zehn et al. also studied the secondary
recall response by these T cells. This is beyond the scope of the question we are trying to
define, thus its discussion is omitted here.
Finally, I'd like to comment on the CD4+ T cells in these mice experiments. Another
important parameter in this study is the extent of CD4+ T cell response. As we discussed
earlier, much of complexity in vivo is due to the interactions between different cell types.
CD4+ T cells are known to "help" the CD8+ T cell response in several ways. Since only the
class-I-restricted epitope was mutated, we can fairly safely assume that the class-II-
restricted epitopes presented by Listeria remain un-altered. This implies that the CD4+ T
cell response in mice infected with different APLs had comparable CD4+ T cell response.
In other words, though CD8+ proliferated to different extents, they may have received
comparable amount of "help" from CD4+ T cells.
4.2.3 A task defined
The study by Zehn et al. is a particularly good case study for modeling consideration,
because many variables associated with an in vivo setting have been well controlled.
These include the stable presentation of epitopes by Listeria monocytogenes, comparable
binding affinity of APLs to MHC, and most importantly, a relatively uniform CD4+ T cell
response. They recorded proliferation amount and surface marker expression over the
entire course of primary proliferation, which are the type of data we seek. Finally, some
counter-intuitive trends in their observations present a great opportunity to utilize
modeling and simulation.
The modeling goal is to construct a mechanism for CD8+ T cell proliferation in vivo,
which is capable of reproducing the following behaviors qualitatively: 1) a lower-affinity
APL may induce CD8+ T cell proliferation comparable to that of a higher-affinity APL
during the initial proliferation; 2) lower-affinity APL stimulated T cells exit LN slightly
earlier; 3) the peak in proliferation occurs earlier for T cells stimulated with lower-affinity
APLs and at a lower peak size. In addition, the model must account for CD4+ "help" at
least in a coarse-grained manner. This model must be able to explain why CD8+ T cell
response in vivo is a "dampened" version of what happens in vitro. If a model can achieve
these goals, it can make predictions regarding the mechanisms underlying the
phenomena described above and suggest additional experimental tests. Such iterations
between experiments and model refinement can then help provide mechanistic
underpinning to the puzzling observations.
4.3 How CD4+ T cells help CD8+ T cell response
In this section I will provide some necessary background information on the two main
venues for CD4+ T cells to provide help to CD8+ T cells during primary response:
licensing of immature DCs and secretion of interleukin-2 (IL-2).
4.3.1 The "licensing" of DCs for more effective Ag presentation
In order for either CD4+ or CD8+ T cells to detect the invasion by their cognate Ag, APCs
must first process and present this Ag in the form of class-II or class-I MHC, respectively.
Again, most often these APCs are DCs, which we will limit our attention to in the following
discussion. Immature DCs have low expression of MHC and costimulatory molecules such
as CD40 and CD80. The capture of Ag-derived signal and interactions with CD4+ T cells
may drive them through a maturation process, which enhances the expression of MHC
and costimulatory molecules and readies DCs for T cell engagement. Detailed
characterization of this process and of the different maturation states of DCs are subjects
of intense research efforts. Some features of DC maturation are necessary for the model
we're building, though caution must be taken to avoid introducing an excess of irrelevant
complications.
Mechanism of DC maturation and CD4+ T cell help
Consolidating the findings of several pertinent experimental studies, it appears that Ag-
derived signal may come in several different incarnations, including fragments of necrotic
or apoptotic cells, toll-like receptor (TLR) ligands, and inflammatory cytokines (6).
Exposure to one of them or a combination of several leads to the maturation of DCs.
There is ongoing debate regarding how different maturation signals may lead to different
DC maturation outcome. For example, some believe that inflammatory cytokine-driven
maturation, in the absence of TLR, leads to a kind of "unlicensed maturation" which
ultimately results in a tolerance response, rather than effector response (7). As far as our
modeling task is concerned, it is sufficient to know that some pathogen-derived signal is
needed to "prime" the DCs, and an important outcome of such priming is the up-
regulation of MHC-II, which would enable DCs to more readily interact with CD4+ T cells.
In other words, inflammation can help to enhance class-II pMHC presentation to CD4+ T
cells.
These CD4+ T cells are then able to "license" DCs for better class-I MHC presentation.
Specifically, researchers found that without CD4+ T cells, naive CD8+ T cells do not
develop into cytotoxic T lymphocytes (CTLs) when stimulated in vitro (8, 9). It was
proposed that after interaction with mature DCs presenting cognate class-II MHC, CD4+ T
cells upregulate CD40, which then bind to CD40 ligands (CD40L or CD154) on the DC
surface, causing DCs to process MHC-I epitopes to be recognizable by CD8+ T cells (8, 9).
An alternative explanation involving CD40-CD40L interactions stipulates that upregulated
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CD40Ls on DC surface bind to the CD40 on CD8+ T cells to facilitate CD8+ T cell and DC
conjugation, although this route has been shown to make a relatively small contribution
(10-12). Given the present state of mechanistic understanding, we need to be extra
cautious if a molecular signaling model was to be constructed. But from these limited
experimental observations, it appears that the activation of CD4+ T cells precedes that of
CD8+ T cells.
Functional consequence of CD4-help in vivo
Initially, it was largely believed that without the licensing of DCs by CD4+ T cells, only the
long-term memory function suffers and the effector functions of CD8+ T cells are not
affected. For example, Sun and Bevan showed that in a CD4+ T cell-deficient mouse,
memory function is impaired, and the CD4+ help is provided in an Ag-independent
manner (11). In other words, the CD8+ T cells are still able to proliferate vigorously and
perform cytotoxic killing in the primary response.
Meanwhile, Shedlock and Shen, as well as Janssen et al. argued the exact opposite,
namely, CD4-help is required for priming but not so much for maintenance of memory
function (13, 14). More recently, Smith et al. found that in the case of HSV infection, CD4+
T cell help is required for primary cytotoxic functions (15). Moreover, the "help" is
provided in an Ag-specific manner. Specifically, CD4+ and CD8+ T cells must engage the
same cognate DC to become activated, because in chimeric mice whose DCs either express
MHC-I or MHC-II but not both, the immune response to an HSV infection is poor.
The modeling implication here is that linking CD4-help to any specific functional
outcome requires caution, because this relationship remains largely unclear and likely
highly dependent on what type of Ag and TCRs are used for experiments. Before more
definitive results emerge, model implementation should strive for high flexibility, so as to
accommodate different licensing-function relationships.
Interchangeability between inflammation and CD4-licensing in DC maturation
There also appears to be a degree of redundancy between licensing delivered by helper
(CD4+) T cells and licensing via inflammatory signals, especially during acute infections.
Depending on the offending pathogen, the degree of inflammatory response may differ.
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With severe inflammation (e.g. Listeria monocytogenes (11)) , which typically occurs in
vivo during acute viral or bacterial infections, the need for CD4+ help may be bypassed
(15, 16). Several other infectious agents, including ectromelia, vesicular stomatitis virus,
human immunodeficiency virus, Epstein-Barr virus, influenza, and cytomegalovirus have
been shown to bypass at least partially CD4 help (17-20). One possible mechanism, as
investigated by Johnson et al. in a 2009 publication implicates these infectious agents'
ability to directly induce CD40L expression on DC, thus stimulate helper-independent
licensing of DCs (21).
Modeling implications
Presently no definitive conclusion can be made about how, under different infection
conditions, DC licensing takes place and how it affects either primary or secondary
immune response. However, the diverse opinions and findings reviewed here seem to
agree that 1) some form of "help" is needed to activate DCs; 2) the degree of "licensing"
has several levels, rather than a binary "on"-"off' switch; 3) there likely exist multiple
mechanisms, and the relationship between them may be relatively fluid to ensure rapid
and efficient Ag presentation and immune response. While our model must account for
the DC licensing, we do not have comprehensive knowledge regarding this matter to opt
for one detailed mechanism over another. We must develop a model with a high degree
of flexibility that allows for 1) easy conversion between different mechanisms for
"licensing"; 2) straightforward incorporation of new experimental findings.
4.3.2 IL-2 biology
Another important type of "help" provided by activated CD4+ T cells for CD8+ T cells is
the secretion of IL-2. In this sub-section, I will review the current understanding on the
production, consumption and functions of both IL-2 and IL-2 receptors (IL-2R).
First isolated in early 1980s, IL-2 is the first interleukin to be discovered (22). It is a
15,000-kDa, a-helical single protein with variable glycosylation. It has been implicated in
almost all stages of adaptive immune response. In the sub-sections below, I will review
the secretion of IL-2 and its functions during the primary response.
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The receptor of IL-2, or IL-2R, is a hetero-trimeric protein expressed on the surface of
lymphocytes. The a-subunit of IL-2R, CD25, is one of the earliest activation markers of T
cell activation. In the experiments by Zehn et al., it was also one of the two surface
markers (the other being CCR7) that showed different expression kinetics between high-
and low-affinity APL experiments (5). This implicates CD25 as an important player in the
model we seek to build. A few paragraphs will be devoted to reviewing the biology of
CD25 in our discussions later.
IL-2 and the development ofprimary function
IL-2 has long been shown to increase the rate of division in activated T cells in vitro, as
well as the differentiation of effector function (CTLs) (23). When examined in vivo,
however, the picture is less definitive. Mice deficient in IL-2 or subunits of IL-2R have
been used to study the impact of IL-2 on primary effector functions. Earlier studies tend
to show that the proliferation of T cells appeared to only reduce marginally. Effector
functions did not suffer much impairment, if any at all. These experiments used a range of
different antigens, including lymphocytic choriomeningitis virus (LCMV) (24), OVA (25),
vaccinia virus and LCMV (26), and male Ag (27). A caveat associated with these results is
that the T cell proliferation may have resulted from an autoimmune response. IL-2
signaling is crucial for the suppression of autoimmunity. Thus, in experimental systems
where transgenic T cells were adoptively transferred into the IL-2 or IL-2R-deficient
hosts, autoimmunity may cause over-growth of T cells and mask the proliferation
deficiency due to impaired IL-2 signaling (8, 28, 29).
More recent studies took care to circumvent this caveat. For example, Williams and
coworkers devised a chimeric strategy, where CD25-deficiency is induced in mice with
normal thymic development (29). This and some other similar studies argue that IL-2
deficiency mainly impacts the long term memory effect, while it influences the primary
effector function in a quantitative, rather than qualitative, manner. IL-2 deficiency leads
to less proliferation, rather than no proliferation.
The most direct evidence comes from the study by Turner et al. They measured the
proliferation kinetics of the same set of APLs studied by Zehn et al., and found that IL-2
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treatment allows T cell to divide for more rounds (30). Thus, IL-2 signal likely affects
primary proliferation in a quantitative manner by altering the kinetics of cell division,
rather than causing qualitative changes.
The kinetic profile of IL-2 during primary response
Satoguchi et al. have previously shown that the source of IL-2 during a primary response
is confined to CD2510w CD4+ nonregulatory T cells (31). It can also come from activated
CD8+ T cells, albeit to a much lesser extent. There is small amount of basal IL-2 present in
secondary lymphoid organs (SLO) prior to the activation of CD4+ or CD8+ T cells, though
the exact source of such IL-2 is unclear (6). Activated DCs have been implicated in an
experimental study by Granucci et al (32). For our model, these less likely sources of IL-2
during primary proliferation will not be considered.
Sojka et al. recorded the time-course of IL-2 secretion in naive T cells upon stimulation
with Moth Cytochrome C (MCC) mixed with PBS buffer, both in vitro and in vivo (via
adoptive transfer). They found that with potent Ag stimulation in vivo, activated CD4+
helper T cells began to secret IL-2 as early as within 1h of infection. Then the number of
IL-2 secreting cells rose for 6h before reaching a plateau, which persisted for 4-5h.
Afterward IL-2 secretion declined over a period of about 10h until barely detectable at
22h (33). In addition, at higher T cell density, the decline in IL-2 secretion began much
earlier.
What intracellular mechanism turns up and down the IL-2 secretion? Though the
pathway has not been fully delineated, several key molecules involved in the regulation of
IL-2 secretion have been identified. There appears to be feedback regulation between IL-
2 signal received by an active CD4+ T cell and its ability to further secret IL-2. For
example, Gong and Malek showed that this IL-2 signaling, in addition to TCR signaling, is
required for the expression of a transcription suppressor called Blimp-1. Blimp-1, in turn,
may cause a decline in the transcription of IL-2 and CD25 genes (34). Martin et al.
suggested that Blimp-1 dose so by directly suppressing the i12 gene (35). Villarino et al.
identified the STAT family transcription factors as important mediators of the negative
feedback in IL-2 secretion (36). Unfortunately our current understanding of the JAK-
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STAT pathway remains too rudimentary to allow for detailed modeling. Therefore, the
model will reflect the connection between IL-2 signal and its own rate of synthesis
without specifying the molecular mechanism.
IL-2 and T cell egress to periphery
IL-2 signaling may also play an important role in directing activated T cells away from
SLO and toward peripheral tissues where they carry out effector functions. There is at
least some indirect evidence to show that this is indeed the case. IL-2 appears to achieve
this by contributing to the downregulation of CD62L (L-selectin) and C-Chemokine
Receptor type 7 (CCR7) and the upregulation of receptors S1P1 .
Heavily expressed on the surface of naive T cells, CD62L and CCR7 are two centrally
important chemokine receptors in regulating T cell entry to LN and their migration within
LN (37). To facilitate T cell egress from LN, CCR7 and CD62L expression need to be down-
regulated (38). S1P 1 molecules are receptors for a lysophospholipid, phingosine-1-
phosphotase (S1P). They are normally expressed on T cells but transiently
downregulated after T cells are activated, in order to temporarily retain them in LN,
where they can proliferate and mature. Then S1P1 is upregulated to enable the T cells to
egress from LN (37, 39). Earlier experimental results implicate a feedback regulation as
the cause of such down-regulation; namely, increasing SiP exposure leads to the down-
regulation of S1P1 (37). More recent studies have shown that IL-2 is a very effective
inducer in the down-regulation of CCR7, CD62-L and S1P 1 via the p1008 subunit of kinase
P13K (39, 40). These results are especially useful, as we recall that, in Zehn et al.'s assay of
surface markers during primary proliferation, the only difference between T cells
stimulated with high- and low-affinity APLs is the downregulation of CCR7 and CD25 (5).
The regulation of CD25 during primary response
The receptor of IL-2, or IL-2R, is a hetero-trimeric protein expressed on the surface of
lymphocytes. The three protein subunits are the c, P and y chains, which are alternatively
known as CD25, CD122 and CD132. Importantly, all three subunits are required for the
high affinity binding between IL-2 and IL-2R. Without the complete IL-2R complex, the
binding is very weak and is unlikely to initiate much downstream activity (41).
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The high-affinity hetero-trimer does not exist in the pre-assembled form in naive T
cells because the expression of the subunits varies significantly. CD132 is the most
prevalent, being expressed by almost all hematopoeitic cells. CD122 is induced on Ag-
activated CD4+ and CD8+ T cells, as well as regulatory T cells (Tregs). Both these units
bind to other cytokines besides IL-2. CD25 is virtually absent in all naive conventional
CD4+ and CD8+ T cells (as opposed to Tregs), and is only induced by Ag-activation (6).
CD25 on its own binds IL-2 with relatively low affinity (Kd-10-8M). But this association
promotes the non-covalent binding with CD122 and CD132 to form the complete
receptor, meanwhile stabilizing the binding of IL-2 (Kd-10-11M). Then the cytoplasmic
tails of CD122 and CD132 associate with Janus kinase 1 (Jak-1) and Jak-3 (6). In this
manner, IL-2 signaling enters the Jak-STAT signaling pathway, ultimately leading to
relevant gene transcriptions in the nucleus. Newly formed IL2-IL2R complex formed on
the surface of T cells are internalized very rapidly (ti/2-10-20min). CD25 appears to
recycle back to the surface, though the extent of which is unclear. Meanwhile the other
subunits, along with IL-2, are degraded (42).
The expression and regulation of CD25 are intimately connected to how IL-2 is
consumed in LN by activated T cells, thus CD25 kinetics influences how CD4+ and CD8+ T
cells interact. However, a comprehensive understanding of how CD25 expression is
regulated has yet to emerge. What we do know is that 1) CD25 is one of the earliest
markers to be upregulated after T cell triggering; 2) a positive feedback between IL-2
signaling and IL-2R expression is likely (43). There appear to be multiple pathways
leading to the enhanced gene transcription of CD25, including one via stimulation of
STATS and one pathway that directly acts on the cd25 gene to render the chromatin more
accessible to transcription factors (44).
Additional comments on time delay and diffusion
A finite time delay exits between IL-2-IL-2R binding and the regulation of CD25 and IL-2
expression. This time delay corresponds to the time of signal transduction, as well as the
transcription and translation of new genes. While this time delay most certainly exists, to
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obtain an estimate for its duration requires better understanding of the underlying
molecular mechanisms.
Finally, diffusion and distribution of IL-2 molecules in living SLO is important for
assessing how localized or globalized CD4+ and CD8+ T cell interactions are. While it has
not yet been directly addressed in available open literature, some indirect evidence
suggests that its diffusion is a slow process. In earlier works, an estimate for the
diffusivity based on molecular weight had been applied to various cytokines (45).
Diffusivity estimated based on the physical characteristics of a collagen matrix were
considered to closely mimic the diffusivity in vivo. Via this approach, IL-2 diffusivity is
likely on the order of 10-7 cm2/s. One could then imagine that if potential "consumer" cells
for IL-2 are widely distributed, IL-2 molecules will be restricted around its "producer"
cells (i.e. activated CD4+ T cells). Indeed, Snyder performed immuno-histo-chemical
staining of IL-2 producing tissues and observed a ring of IL-2 protein closely surrounding
the secreting cells (46). This implies that transport limitation may come into play.
In summary, activated CD4+ T cells help the CD8+ T cell response via at least 2
channels: licensing of DCs and secretion of IL-2. Though most of the mechanistic details
remain unavailable, there is a significant amount of qualitative understanding regarding
processes such as the production, distribution and consumption of IL-2. Should any of
these dynamical processes become relevant for modeling purposes, one can employ the
strategy used in Chapter 2 by first postulating a simple, qualitatively correct "mechanism"
(e.g. dose-response curve postulated in Chapter 2). As researchers uncover more
signaling details, a more realistic version can be substituted in. Therefore, in the model
development stage, we must also strive for greater flexibility in the computational
framework, in anticipation for future expansion.
4.4 A hypothesis for CD8+ T cell proliferation
Guided by the modeling objective and model requirements described in the previous
section, I constructed a hypothesis to describe CD8+ T cell proliferation in vivo given TCR-
pMHC binding affinity. A "resource competition" is built into the model to capture some
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key features of the experimental observations by Zehn et al. (5). The "resource" must
possess the following characteristics:
1. It enhances T cell division.
2. The activated, dividing T cells need to have received a threshold dose of such
"resource" to be able to leave LN and exit into the blood.
3. The total available amount of such "resource" is comparable in LN infected with
different APLs.
The "competition" over such "resource" achieves the "dampening" effect observed when
CD8+ T cell proliferation occurs in vivo as opposed to in vitro. The details are as follows:
1. Initially, due to lower TCR-pMHC binding affinity, fewer naive CD8+ T cells are
activated in an LN infected with low-affinity APL.
2. Since the total availability of the "resource" is the same, in the case of the lower-
affinity APL, each activated T cell receives more such "resource", since their total
number is smaller.
3. More intake of this "resource" per cell means the enhancement in cell division rate
is greater, in T cells activated by the lower-affinity APL. Though initially fewer T
cells begin to divide, these T cells divide more frequently. This compensates for
the disadvantage of a lower TCR-pMHC binding affinity and allows for comparable
initial growth kinetics.
The observations regarding the size and timing of expansion peak can be explained as
follows:
1. Since the "resource" intake is higher for T cells activated with lower-affinity APLs,
their cumulative exposure to such resource will reach the threshold dose required
for exit earlier.
2. Earlier exit means that their residence time in LN is shorter, which means fewer
rounds of total division, thus overall a small peak size.
Combining observations of several experimental studies, and also taking into
consideration data availability, I found IL-2 to be the best candidate for such "resource".
In a mouse infected with the lower-affinity Ag for CD8+ T cells, fewer naive CD8+ T cells
are activated initially. However, the mutations that generated the APLs do not affect the
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epitopes for CD4+ T cells, thus we expect the number of CD4+ T cells initially activated to
be about the same regardless of which APL is used. Thus the production of IL-2 is also
comparable in all cases. Then if there are fewer T cells competing over a fixed amount of
IL-2 in the LN, each T cell can form more IL-2 complexes. As reviewed in the previous
section, IL-2 has been found to enhance the rate of division and increase the maximum
rounds a cell can divide. Therefore T cells stimulated with low-affinity APL divide faster
than those in a mouse infected with a higher-affinity APL, and in so doing compensate for
their lower triggering rate. Thus the initial proliferation kinetics can appear comparable.
We can also explain why CCR7 and CD25 downregulation happens earlier on CD8+ T
cells stimulated with the lower-affinity APL, and cell egress to periphery occurs slightly
earlier. If a threshold amount of cumulative IL-2 signal is required for egress to begin,
then T cells stimulated with lower-affinity Ag will reach this threshold faster, because the
competition over the fixed amount of IL-2 is less severe. As T cells approach this
threshold exposure, IL-2 signaling facilitates the upregulation of S1P 1 , and
downregulation of CD62L and CCR7, resulting in T cell egress from LN. The
downregulation of CD25 can be seen as the consequence of reduced availability of IL-2.
As more and more activated CD4+ T cells accumulate sufficient IL-2 exposure and exit LN,
the number of IL-2 producers declines. On the other hand, a large number of IL-2
consumer cells still remain in LN, since in a typical primary response CD8+ T cells
proliferates far more than CD4+ T cells. The combined result is a decline in IL-2 level
while T cells exit LN. Since the expression of CD25 is positively correlated with IL-2
signaling, the expression of CD25 also decreases.
4.5 Model and parameters
After identifying IL-2 as the key "resource" in our hypothesis, the next step is to cast the
hypothesis in mathematical language and implement the corresponding computer
simulation to assess its veracity. In this section, I will first present the differential
equations corresponding to the hypothesis, which is followed by a discussion of the
parameters used.
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4.5.1 Mathematical model
Ordinary Differential Equations (ODEs) have provided researchers with a powerful tool
for studying the kinetics of cell proliferation, including the proliferation during an
adaptive immune response (47, 48). Attempts have also been made to model the
development of memory T cells using ODEs (49). On the molecular level, ODEs have long
served as a primary tool for simulating the kinetics of molecular reactions, including those
in biological systems. In this project, I opted for a model based on a system of coupled
Delayed Differential Equations (DDEs). ODEs are a special case of DDEs with a zero time
delay. The choice of DDEs instead of ODEs is motivated by the need for a signal-
propagation time delay discussed at the end of the previous section. In the next few
paragraphs, I will first describe the modeling of T cell activation, division, egress, as well
as DC licensing. Then the dynamics for IL-2 production and consumption are presented,
after which I will describe how to connect these two levels of dynamics.
The main types of cells simulated are naive and activated CD4+ and CD8+ T cells, and
DCs of different maturation stages. They are represented as N4, N8, T4, T8, and D, D*, D**
respectively.
1. Activation of naive T cells.
We postulate that a cognate DC can be in 3 states of different degrees of "licensing":
unlicensed (D), partially licensed by inflammatory signals (D*) and fully licensed via
cognate interaction with a CD4+ T cell (D**). The conversions can be represented by the
following equations:
D k' >, D*
D+ N4 P : D** + T0
0 ~Eq. 4. 1D* + N4 :D** + T E.41
D** + N4 :D** + T
The first equation represents the "licensing" by inflammatory signals at a rate ki. A
cognate interaction between a DC and a naYve CD4+ T cell can lead to both the activation
of the T cell and the full "licensing" of the DC, as represented by the next 3 reactions. The
rates follow p << p* < p**.
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CD8+ T cells, on the other hand, do not "license" DCs. The recruitment from the pool
of naive CD8+ T cell is represented by the following:
D + N8 q ) D + T0
D* +NS q* > D* + T Eq. 4. 2
D** + N : D** + T
Note that these 3 reactions do not alter the states of DCs. To enforce the condition that
CD8+ T cell can only be activated on licensed DCs, simply let q->0 and q**>>q*. We do not
expect these rates (i.e. ki, p, q) to change significantly with respect to IL-2 concentration in
the LN, thus they remain constant throughout the simulation. Naive T cells die at
extremely low rates and can live for decades, which vastly exceeds the time horizon of
this model (50). Thus, in this model we neglect the death of naive T cells. Finally, the DCs
may die at some rate:
D,D*,D** I" >0
The associated differential equations for the DC population are the following:
dD =-kD- pDN4 - gDD
dt
dD- kiD + pDN4 - p*N4 - gDD Eq. 4. 3
dt
dD p*D*N4 
- D**
dt
Differential equations for the naive CD4+ and CD8+ T cells are the following:
dN4
dt -(pD+ p*D* + p**D**)N 4dt E.4
dN8 
-(q*D* +q**D** )N8dt
2. Division of activated T cells.
The division of individual T cell is a stochastic process. The time of division and the total
rounds each cell may divide before stopping differ from cell to cell. In this mean-field
treatment, however, we must specify the maximum rounds of divisions as M4 and Ms. The
activated T cell populations fall into different "generations", depending on how many
times they have divided. This avoids the need to dynamically manage a variable number
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of differential equations, thus significantly reducing the computational cost. Additionally,
T cells may exit from LN into the periphery after a certain criterion (to be discussed later)
is met. Finally, the activated T cells may die at rates ;4 and ge respectively.
T4' X >2T1 i= 0.. M 4 -1
T,, 2T8,''+ j = 0.. M8, -1
T E 4  i 0.. M4  Eq. 4. 5
T8' E8  j=O.. M8
T 9k0 k =4,8
The associated differential equations are
dT0d= (pD + pD* + p**D**)N 4 - (Ao + E4 + 4)T40dt
dT'
dt= 2_- -(A, +. 4F 4 )T i=1...M4 -dt
dT M4
4t = 2XM4 _1T4* -C4 + g4 4"
dt
dT~d =(qD+q*D + q** )N - (o + E8 +G8-8dt 8 )
d8J 877 T"' j + 8 8 8T j=1... M8dt -8
dT Mg
_8 M -1 8M"-1 , 8Mgdt 818 -(C+ 8 
1
Eq. 4. 6
-1
It's important to note that many of these rate parameters are not constant, and instead
dependent on the dynamics of IL-2, which will be described next.
3. Dynamics of IL-2 and IL-2Ra (CD25).
We treat the formation and degradation of IL-2 - IL-2R complexes in a coarse-grained
manner as follows:
R+Le : "C k, : 0 Eq. 4. 7
kogf
Here R denotes the concentration of CD25 (or the concentration of high-affinity, complete
IL-2R) on a T cell. As discussed in the previous section, the number of high-affinity IL-2R
is dictated by the number of CD25, because the other two subunits of IL-2R are
constitutively expressed. L and C denote the number of IL-2 near the cell surface and the
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number of IL-2 - IL-2R complexes, respectively. Here we assume the diffusion of IL-2
through the LN space is infinitely fast, compared to the other time-scales in the model,
therefore the concentration near any T cell surface is the same as the concentration of IL-
2 far away.
Also recall from the previous section that the production rates for IL-2 and CD25
depend on the IL-2 signal the cell has received. We postulate that the rate of IL-2 and
CD25 production depend on the IL-2 complex concentration in a sigmoid manner. Busse
et al. have used a Hill's equation-type formulation for the rates of IL-2 and IL-2R
expression with some success (51). Here we apply a similar strategy as follows:
dR'k
=y-k R L+kCk 
-gRRdt k on k off Cq.4.k
dC .Eq. 4. 8
=L k kOfC-gCk i=1...M, k=4,8
dL 4on k off 
T L = { Ci T L jT1
k i i=O..M4  k=4,8 i k=4,8 i
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Y '(t= YO .- n, {(t{0 - , -n Eq. 4.9
1+ -. I 1+ .i (t-Ck( - Ty) Ckt-
i =1I... Mk, k= 4,8
The first 2 sets of differential equations apply to both CD4 and CD8 T cells. The
concentration of IL-2-IL-2R complexes, C, is used to measure the strength of IL-2 signal.
The rate of CD25 production, y, depends on Cin a Hill's equation-manner with a time lag,
zY. This time lag accounts for the time required for IL-2 signal (initiated upon IL-2-IL2R
binding on cell surface) to propagate through the intracellular signaling network until
reaching the nucleus, and the time for IL-2 and CD25 mRNA transcription. And given that
IL-2 and CD25 upregulation can begin within 10 min of stimulation, this time delay is
likely very short. The rate for IL-2 production is calculated in an analogous manner with
different parameters. The rate for cell division, A and 1, are also calculated in a similar
manner as:
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Ak(t)= l+L (t) Eq. 4. 10
101+ 
n 71 + n(t - ) C (t - ,)
This reflects the enhancement in cell division due to IL-2 signaling. An important
difference is that only CD4+ T cells produce IL-2 after being activated. Therefore, in the
final equation for the total IL-2 in the LN, the production term (the first summation) only
has contributions from CD4+ T cells.
dL = IXT- I (kR, L--kOTC L-LL IT Eq.4. 11kw7  on- kXf Ti-
k=4,8 i dt i=O..M4  k=4,9 i k=4,8 i
The exit criterion is based on the total amount of IL-2 signal a cell has received, namely
f Cdt > Z* where Z* is a threshold for the cumulative IL-2 complexes. How much IL-2
signaling is necessary to turn off S1PI, CCR7 or L-selectin (i.e. the value of this threshold
Z*) cannot be estimated from limited experimental data presently available. Thus its
value requires tuning. More details can be found in the next subsection on parameters.
These equations are implemented as a system of Delayed Differential Equations
(DDEs) and solved using a DDE solver available in MATLAB. The integrator keeps track of
the previous steps (history) according to a time lag specified by the user.
Besides using DDEs rather than the more commonly used ODEs, this model contains
another unusual feature, which concerns the initial conditions. As a zero-th generation T
cell divides into two first-generation T cells, all cellular materials are divided between the
two daughter cells. For simplicity, we assume the division of cellular materials is even
between the 2 daughters. Then the initial value for R1 and Care half of RO(t- 1 ) and
CO(tO_ ) where to. 1 is the time when the division takes place. Because of the coupling
among these equations, it is impossible to know a priori the values of either RO(to0 ,) or
to,. This also applies to the initial values of later generations. To address this issue, at
the time when this division happens, the DDE integration of pauses, and the values of
1
Rk( 0 .1 ) and C'(t0>1) at that time are updated as R'(to= -RO(t~ 1 ) andk k ~2 k0-)
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1
C (te)= -CO(t s). Using this newly updated initial condition, the same set of DDEs are2
integrated until the next division time.
One may ask: how is the "generation-crossing" time determined? While in reality, each
cell of the same generation divides at different times (i.e. different values of tii+1), a
mean-field model cannot accommodate that. In the model it is set to be the time when the
cell number of the next generation exceeds a threshold. For example, if this threshold is 1,
then the integrator stops as soon as the total cell number of the next generation exceeds
1. And the time is recorded as ti>i 1+. Such pause and updates are performed for each
"generation crossing" for both CD4+ and CD8+ T cells, resulting in a total of M4+M8
pauses. The MATLAB@ "event" function is used to locate these "generation-crossing"
times. The other initial conditions are straightforward. An estimated 10% of the 3000
adoptively transferred T cells may arrive in the LN (Scott Weber and Paul Allen, personal
communication). Thus the value of 300 is used as the initial number of naive CD4+ and
CD8+ T cells, N4 and N8. The initial amount of CD25 and IL-2 complex on newly recruited
T cells are zero, i.e. R (t = 0) = CO(t = 0) = 0. All DCs are initially in the un-licensed state,
i.e. D* and D** are zero. The initial value of D is set to be of the same as T cells. The only
knowledge regarding the initial value for IL-2 molecules available in the LN is that a low
basal amount of IL-2 is present prior to primary response. Thus the initial value of IL-2 is
another parameter that requires tuning.
4.5.2 Parameter estimation
Some of the kinetic parameters have been directly measured from experiments or
estimated from experimental data. Although they apply to different experimental systems
(types of cells and Ag used, in vitro vs. in vivo, etc), they at least provide an estimate for
the order of magnitude of these parameters in the system we are concerned with. Table
4.1 lists the values of all parameters.
a)
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Symbol Significance Value
ki Rate of DC licensing by inflammatory signals 5x10 5 min-'
p Activation propensity when a CD4+ T cell engages a cognate DC 5x10-6 cell-' m-'
p* that is unlicensed, partially licensed by inflammation, and fully 2.5x10-5 cell' min'
p licensed via interactions with cognate CD4+ T cells 1.3x10~4 cell) min'
q Activation propensity when a CD4+ T cell engages a cognate DC 5x10-7 cell- min-
q* that is unlicensed, partially licensed by inflammation, and fully 3x10-6 cell- mn-
q** licensed via interactions with cognate CD4+ T cells 1.3 x10~4 cell' min'
-', -8 Rate of exit from LN to blood 1x1-4 min
kon Rate of IL-2 binding to IL-2R 1.5x10-3pM'min
koff Rate of IL-2-IL-2R complex unbinding 0.14 min-'
kd Rate of IL-2-IL-2R complex degrading 0.05 - 0.1 min-
Z* Threshold of cumulative IL-2 complex. Above which a T cell is 2000 molecules
qualified to exit from LN into periphery
gD Death rate of cognate DCs 0
g4, ;4 Death rate of activated CD4+ and CD8+ T cells 0
R Rate of CD25 degradation 2x102 min-
gc Rate of IL-2-IL-2R degradation 1x10 min-
Rate of IL-2 clearance 1x10-3 min-'
b)
Parameter & significance Parameters in Hill's Value
eq.
A: Rate of cell division for Lo 5x10-4 cell' min'
activated CD4+ T cells. n) 0.5,1,1.5
KA 20, 40, 60
7: Rate of cell division for no 5x1 04 cell' min'
activated CD8+ T cells. Ng 0.5,1,1.5
Kn 20, 40, 60
y Rate of CD25 production yo 500 molecules cell'min'
NY 0.5, 1, 1.5
Ky 20, 40, 60
0: Rate of IL-2 production by 0o 500 molecules cell-1min-I
activated CD4+ T cells no 0.5, 1, 1.5
K8  20, 40, 60
Table 4. 1: a) Parameters used in the model. b) Parameters in the Hill's equations.
How the value of each parameter was determined is described below.
1. Rate of DC-licensing via inflammatory signals: No experimental data is available to
allow for direct estimate of this rate. The activation rates of naive CD4+ T cells by
cognate DCs (i.e. the rates for DC-licensing via interaction with CD4+ T cells), p,
provide an upper bound (see next), as it is significantly higher than ki. Thus we choose
ki to be one order smaller than pN4.
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2. Rate of T cell activation, p and q: These rates can vary significantly depending on the
quality and quantity of Ag present. Specific values are varied over a range to
represent different Ag. However, the order of magnitude is maintained as specified in
Table 4.1a
3. Exit rate: No direct experimental measurement is available for the kinetics of T cell
exit into the periphery. Zehn et al. showed that in 3 days, intra-LN population size
dropped by about 50% regardless of Ag used for stimulation (5). Assuming this
reduction is mostly due to exit of activated T cells into the periphery, and assuming
the exit is a first-order process with a tl/2 = 3 days, then the rate is about 3x10 4 min'.
Alternatively, we can use Young and cowokers' estimates for T cell population in LN
and the total exit flux of T cells from LN. With 108 T cells in LN and an exit flux about
106 cells per hour, the time to renew all the T cells in an LN is on average about 100h,
which translates to a characteristic time of 3 days as well (details see Chapter 1 (52)).
Varying the exit rate can affect when the peak of proliferation occur. The slower the
exit rate, the more delayed the peak is.
4. Rate for IL-2 binding to high affinity IL-2R and the dissociation of their complex. The
complex formed by IL-2 binding to high-affinity IL-2R has Kd-OnM (6).
5. Base rate of cell division (Lo and r7o): During a typical primary response, activated CD4
and CD8 T cells can divide about 7-8 rounds within the first 3 days, and for CD8+ T
cells, up to 15 rounds in 7 days (8). The typical division rate is approximately one
division per 6-8 hours. Activated CD8+ T cells may divide more rounds than do
activated CD4+ T cells. Therefore, in the model, CD4+ cells can divide up to 13 rounds,
while activated CD8+ T cells may divide up to 16 rounds. Note that the criteria for T
cells to exit from LN into the blood stream do not directly depend on the rounds of
divisions completed by a cell. It is possible for a cell that has divided fewer times than
the maximum to exit from LN. The maximum number of possible division is set to a
large number to ensure that T cell egress is solely due to their meeting the exit
requirements.
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6. Base rate of IL-2 expression used in the Hill's equation (60o): As there are no direct
measurements of the rate of IL-2 or CD25 synthesis by active CD4+ and CD8+ T cells, I
attempted to derive reasonable estimates from related experimental data and
observations. The correct order of magnitude is very important to the validity of this
model. Within a reasonable order of magnitude, sensitivity analyses can then be
performed to see how the values of these rates affect the qualitative behaviors of the
model. Kum et al. studied the kinetics of several anti-inflammatory cytokines induced
by Toxic Shock Syndrome Toxin 1 (TSST-1) in human peripheral blood mononuclear
cell (PBMC), which include lymphocytes and monocytes (53). About 2x106 fresh
human PBMC were stimulated with TSST-1 to reach maximal T cell proliferation in
vitro. Culture supernatants were collected every 0.5h for a total period of 3 days and
assayed for cytokines. The resulted time-profile shows a 2-phase increase in IL-2.
However, the in vivo growth kinetics may be different because of the following. First,
the expression of IL-2 is accompanied by continuous cell division, as well as cell
trafficking into and out of LN. Also, the in vivo IL-2 production by individual cells
appears to be a short burst over about 24 hours (54), much shorter than in vitro.
Therefore, the most relevant data in the time-course generated by Kun et al may be
the initial time points only. These data points yield an estimate of 575pg/(ml.h),
which corresponds to about 2.3x10 9 IL-2 molecules/(ml-h) (IL-2 molecule is about
155kDa or -2.5x1O 7pg). Assuming these IL-2 molecules were produced by the 2x06
cells present in the sample, then each cell makes about 1100 molecules/(cell-h) or
about 20 molecules per cell per min, during the initial phase of IL-2 production (about
12 hours).
7. Base rate of CD25 expression used in the Hill's equation (A): There is no direct
measurement in the open literature. A time profile similar to what was used for IL-2
expression was also unavailable. Therefore, I relied on an even more indirect set of
measurements to obtain an order of magnitude estimate. The cysteine protease Der
p1 has the ability to cleave CD25 on T cell surface and releasing the cleaved fragments
from cell membrane. Schulz et al. performed an experiment where T cells were
isolated from human blood and stimulated with anti-CD3 in vitro (55). Comparing the
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amount of CD25 on untreated cells and cells treated with Der p 1, it appeared that the
fluorescence level difference is about a factor of 1.25, i.e. the concentration of CD25 on
untreated cells is about 1.25 times of those treated. In another set of experiments,
105 such stimulated cells were treated with Der p1. Then the supernatant, which
totaled 2 00pl and contained cleaved CD25, was analyzed over time. The time-profile
showed that in the supernatant, which contained cleaved CD25, by 24h, there was
1600pg/ml CD25 in the Der-p1-treated case, where there was only about 700pg/ml in
the untreated case. Combining these two observations, one can deduce that the total
number of CD25 at 24h is about (1600-700) x 1.25+700=1825pg/ml. Since there was
no IL-2 present, CD25 internalization was unlikely to be significant. Thus, on average,
there was 0.0037pg/cell. Since CD25 has a molecular weight of 55kDa, this number
corresponds to approximately 30,000 molecules per cell. Since the rate of increase of
soluble CD25 appears rather linear up to 24h, this rate translates to 21 molecules per
min per cell.
8. ECso (various K values) and the exponent (various n values) used in the Hill's
equations: These parameters are dictated by the signaling network details and are
difficult to estimate. Different values have been applied to see if they lead to
qualitatively different behaviors. See next section for more details.
4.5.3 Some preliminary investigations and discussion
Parameter requirements for initial kinetics
First, I would like to examine the differential equations to see what Hill's-equation
parameters should be used, in order for T cells stimulated by APLs of different avidities to
grow at comparable rates in the first few days.
Adding the equations for CD8+ T cells through all the generations, one obtains an
equation for the total number of CD8+ T cells:
dT0  dT' dTM g
dt J1.M4 dt dt Eq. 4.12
=(qD+q*D*+q**D** )N, + injT' - ( 8 + g8 ) 1T7j
j=O..M 8 j=0..M8
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The expressions for the total number of CD8+ T cells, weighted average of activation rates
and division rates are as follows:
qD~qD +qD -j=1.-Mg
Tt= 0..M . q D+D*+D** Eq. 4. 13
j=0..M
8
Also note that in the very beginning of cell division, the number of naive CD8+ T cells is
much larger than the activated cells, and cell egress has not yet begun. Therefore, we can
treat Ns as a constant, and drop the egress term. Then Eq. 4.12 becomes the following:
dT
c = qDN, + T Eq. 4. 14dt8 to
Now consider 2 APLs of high and low avidity for TCR, respectively. They are denoted
using subscripts H and L respectively. If their initial growth kinetics are comparable, then
with some algebraic re-arranging:
T H TL
qL ~q N
dTH H L)=)N Eq. 4. 15
dTot / dt
Now using an average number of IL-2 complex per cell, C, and the expression for the rate
of division, one obtains:
_ 
A 
(KL) n,' _KH,
(^L= 70 - n H Eq. 4. 16
Tot + KH n KL
C H (L
Ideally, if one were able to express KH/ KL and CH/ CL as a function of qH/qL, one obtains
the necessary ECso ratio for any given pair of APLs of known activation rates, such that
their initial proliferation kinetics are comparable. Of course, the EC5o value is dictated by
the actual signaling network, and not an input parameter one can arbitrarily vary.
Nonetheless, one may compare the actual ECso with the values that satisfy this equation.
If they differ significantly, then this Hill's equation approximation is inappropriate.
Experimentally, using appropriate IL-2 reporters, one may measure C. ECso (i.e. K) may be
determined using titration with different doses of IL-2 stimulation.
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In simulations, it is difficult to predict the value of C a priori. We can, however,
observe that in order for the initial kinetics to be comparable, it is required that CH/KH <
CL/KL<<1. Simulation using the model shows that this is indeed the case. If the same
value of ECso (i.e. K) is used for both APLs, then though the temporal order in T cell egress
was reproduced, the T cell stimulated by the high-affinity-APL case grows faster than the
those stimulated with the low-affinity-APL case from the very beginning (Fig. 4.1a). By
using a set of values that satisfies KH>KL, however, comparable initial growth kinetics are
reproduced (Fig 4.1b).
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Figure 4. 1: The number of activated CD8± T cells in the LN divided by the initial number of nalve CD8+ T cells
(300) (a and c), and the number of activated CD8+ T cells that have exited from LN (b and d). There are also 200
nafve CD4+ T cells. The maximum numbers of generations an activated CD4+ or CD8+ T cell may divide up to
are 13 and 16, respectively. For the high-affinity APL (solid line), the rate of recruitment on a fully matured DC is
10-4/cell-s and 2x10-4/cell.s.
Effect of varying the Hill's exponent, n
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As shown in Fig. 4.2a, for IL-2 signal (C) less than the ECso (K), smaller n values lead to
higher rates. This trend is reversed if IL-2 signal is above the ECso. It has no effect when
the IL-2 signal exactly equals EC3o. Thus, the effect of this parameter depends on the ECSo
value, which is dictated by the signaling network triggered by IL-2 binding to IL-2R. Fig.
4.2b and c demonstrate this point by showing 2 opposite trends. Three different values of
n, are used to calculate the rate of CD8+ T cell division, while this Hill's exponent for the
rate of CD4+ T cell division, IL-2 production and CD25 expression are kept constant at 0.5.
With a small value of ECso=10, T cells proliferate faster and reach a higher peak size at
larger values of n, (Figure 4.2b), while the opposite is true with a large value of EC5o = 60
(Figure 4.2c).
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What ifAPLs are generated for a class-If epitope?
An interesting question is what happens if class-II-restricted epitope APLs are used
instead? Consider a scenario analogous to what has been discussed so far, but with the
amino acid substitution introduced to a class-II-restricted epitope. What would the
proliferation time-course look like? The key differences between this case and the
previous are listed below. Again the subscripts H and L denote parameters and variables
for the high- and low-affinity-APL case.
NaYve CD4+ T cells initially activated TH > TL
Total IL-2 produced LH > LL
IL-2 available to each cell LH > LL
Rate of cell division )H > XL
Except for the first row, the rest of the trends are expected to be opposite of those in the
Orevious case. An additional difference involves the activation and proliferation of CD8+
T cells. As CD8+ T cell activation may be heavily dependent on the licensing of DCs by
CD4+ T cells, a lower-affinity class-II APL also means a slower pace in DC licensing. Thus
the rate of CD8+ T cell recruitment is restricted, even though the class-I epitopes'
affinities are not altered. The interplay of these competing forces would strongly depend
on the specific parameters used.
Possible future directions
In the previous discussion, I have suggested some potential experimental tests. As the
simulation and analytical results so far imply, the essential feature of this hypothesis lies
in the ability of IL-2 signaling to enhance T cell division rate. Experimentally, one could
perform a very straightforward titration test by supplying activated CD8+ T cells with
different dosages of IL-2. If this hypothesis reflects to some degree the real mechanism,
then activated T cells should divide faster at higher IL-2 doses up to some saturation level.
Secondly, we must verify that in Zehn et al.'s experiments, CD4+ T cells responses were
comparable in mice infected with different Ova APLs. This can be achieved by repeating
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some of the experiments, where a time-course for the endogenous CD4+ T cell response is
recorded.
Experiments are also needed to investigate the scenario where class-II-restricted
epitopes are altered. In fact, such experiments are being conducted at our collaborators'
lab at Washington University in St. Louis (Scott Weber and Paul Allen).
The in silico model can also be expanded in several directions, which I will briefly
discuss below.
1. Regulatory T cells: Regulatory T cells are important in mediating peripheral tolerance.
Unlike the conventional CD4+ T cells, they express a high level of CD25 and Foxp3 (a key
transcription factor in the development of Tregs) (56). Currently this model only
considers conventional CD4+ and CD8+ T cells. However, if experiments in the future
verify that IL-2 indeed played an important role in producing the trends observed by
Zehn et al., then it may become necessary to take into account the presence and activities
of Tregs in the in silico model. This is because one of the main ways Tregs exert their
influence is via a so-called "metabolic disruption". Since Tregs constitutively express high
CD25, they are able to rapidly consume the IL-2 released by activated CD4+ T cells, in so
doing "starve" the dividing conventional T cells of this important growth factor (56). This
"metabolic disruption" will introduce additional "competition" over IL-2, thus altering the
proliferation kinetics of T cells. Introducing Tregs to the model presented earlier is very
straightforward.
2. Spatial considerations: The current model assumes instantaneous equilibration of IL-
2 throughout the LN space. In other words, all cells are exposed to the same amount of IL-
2 on their surfaces. Since LN possesses extraordinary structural complexity and is packed
with hundreds of millions of cells, many of which are avid consumers of IL-2 (e.g. Tregs),
this assumption may not be a realistic one. Busse and coworkers have shown that in
certain parameter regimes, IL-2 diffusion limitation may lead to qualitatively different
results (51). Earlier in the discussion of IL-2 diffusion, a diffusivity estimate was
provided. One could potentially approximate the transport limitation using a
characteristic "length of penetration", thus bypassing the need to simulate multi-scale
reaction-diffusion equations.
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3. Agent-based model: It is possible to implement the same model using an agent-based
approach, where individual cells are explicitly simulated and their histories are tracked.
The disadvantage of this approach is implementation difficulty and computational cost.
Regarding the first difficulty, other agent-based models I have developed previously (see
Chapter 2 and 3) share many common features and can provide readily usable library
functions. The computational cost comes in 2 types. First, a very large memory is
required to keep records of the history of individual cells. One can selectively record a
smaller set of important variables to reduce the memory requirement. The other type of
cost arises from the multi-scale nature of this model. Stochastic simulation of the
molecular reactions may require extremely small time steps. This problem can be
mitigated by using a hybrid approach. For example, the cellular level dynamics are
simulated using a stochastic, agent-based approach, while the kinetics of IL-2
consumption and secretion for each cell are calculated using a mean-field solution. The
benefit of such an agent-based approach compared to a mean-field one includes at least
the following. First of all, it allows for the spatial considerations discussed above, since
the diffusive motion of cells and molecules are now treated explicitly. Secondly, since
cells divide at their own pace, depending on the DCs they encounter, the local cytokine
and cellular environment they face, they will divide for different rounds. This will enable
us to divide the active T cells into subsets, based on their rounds of division and IL-2
exposure. Recent experiments have shown that the more a cell divides, and the more IL-2
signaling it has received, the further it differentiates toward the effector lineage (57).
The authors suggest that the stochastic trajectories taken by individual cells may be
responsible for giving rise to the different functional subsets of activated CD8+ T cells,
which later develop into different effector and memory subclasses. In light of these
experimental observations and hypothesis, an agent-based approach described here may
be very helpful in suggesting experimental designs to test this hypothesis.
4.6 Some concluding remarks
In conclusion, I would like to re-emphasize the necessity and efficacy of a multi-scale
perspective toward the study of biological systems, which I elaborated on in the opening
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chapter. Through the projects covered in the subsequent chapters, I hope that I
succeeded to some extent in delivering this message. And in addition to that, provided
some mechanistic insights on a few very important and difficult questions in immunology,
and added new modeling tools for future explorations.
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